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Measurements of vascular function can be used to assess the risk of 
cardiovascular events such as myocardial infarction and stroke due to their informative 
and noninvasive nature. The overall theme of this dissertation is centered around the 
measures of vascular function.  In the first study, we determined if ambulatory (24-hour) 
blood pressure measurements could improve endothelial function, a key measure of 
peripheral vascular function, as acting as ischemic preconditioning.  The second study 
evaluated a new measurement of arterial stiffness, heart-thigh pulse wave velocity 
(htPWV), that allows noninvasive, minimally intrusive, and user-independent acquisition 
of pulse wave velocity. In the third study, another key measure of vascular function, 
carotid arterial compliance, would be augmented during the simulated diving maneuver 
that is known to produce complex hemodynamic responses. The rationale for this project 
is that brief periods of ischemic preconditioning improve endothelial function, arterial 
stiffness is an excellent predictor for morbidity and mortality, and that during the diving 
maneuver, arterial compliance is likely augmented to buffer increased arterial blood 
pressure/pulsatile stress and maintain continuous perfusion during bradycardia. 
Accordingly, the following three specific aims were tested: (1) to determine if 24-hour 
ambulatory blood pressure monitoring would enhance endothelial function, (2) to evaluate 
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the agreement of an established measure of arterial stiffness, carotid-femoral pulse wave 
velocity (cfPWV), with the new measure htPWV (3) and to determine the influence of the 
simulated free diving maneuver on arterial function. 
In the first study, we measured endothelial function using flow-mediated dilation 
before and after 24-hours ambulatory blood pressure monitoring. We found that 
ambulatory blood pressure monitoring did not influence endothelium-dependent 
vasodilation acting via ischemic preconditioning. In the second study, we evaluated the 
agreement of this new methodology htPWV with the well-established cfPWV. We found 
that the automatic htPWV method has potential as a screening device for assessing 
arterial stiffness in a clinical setting due to its agreement and strong correlation with 
cfPWV. In the third study, we measured the cardiovascular responses that occur during 
simulated free diving. We found that simulated free diving results in bradycardia, 
increased mean arterial blood pressure, total peripheral resistance, arterial compliance, 
carotid blood flow velocity, and decreased cardiac output and atrial stiffness. Taken 
together, the overall findings from this dissertation study highlights how vascular function 
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CHAPTER I.  INTRODUCTION 
 Cardiovascular disease is currently the leading cause of morbidity and mortality in 
the United States (55). The prognostic utility of arterial blood pressure for cardiovascular 
disease is well established (129). However, measurements of vascular function can also 
be used to assess the risk of cardiovascular events (e.g., myocardial infarction and 
stroke) due to their informative and noninvasive nature. These key measures of vascular 
function include endothelial function and arterial stiffness/compliance.  
 Endothelial dysfunction is one of the earliest indicators for the development of 
atherosclerosis (152). In humans, endothelial function is often measured via flow-
mediated dilation (FMD) using ultrasound to access the reactivity of an artery following 
cuff occlusion. An increase in 1% of FMD results in an 8-13% decreased risk of 
cardiovascular events (63, 101, 130, 191). In addition to risk stratification, measurements 
of endothelial function can be used to access the efficacy of interventions (90, 138).    
  Arterial stiffness is an established measurement of vascular dysfunction (76). 
Arterial stiffness is often measured via pulse wave velocity (PWV) using arterial 
tonometers (or pressure transducers) and has been shown to be a strong predictor of 
cardiovascular disease (76) due to the associated increase in ventricular afterload and 
end-organ damage (118). Additionally, PWV is increased in the presence of aortic and 
carotid calcification seen with advanced atherosclerotic plaque development (194). There 
is substantial evidence that increased arterial stiffness is predictive of cardiovascular 
disease and mortality (150) although it has yet to become widely used in clinical settings 
due to its technical nature.   
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 Arterial compliance is important for arterial health as reduced compliance 
(decreased change in volume of a vessel for a given change of pressure) can increase in 
the incident pressure waves and reflected pressure waves resulting in elevated systolic 
blood pressure (114). With decreased buffering capacity of elastic arteries, the 
microvasculature is exposed to increased pulsatility resulting in injury to the capillary 
networks and end-organ damage (e.g., brain and kidney) (107). Moreover, systemic 
arterial compliance increases with exercise (23), as such arterial compliance may be 
augmented during periods of increased cardiovascular demand to buffer elevated arterial 
pressure waveforms. 
 Therefore, a comprehensive investigation of vascular function can be used to 
evaluate the effectiveness of an intervention on improving cardiovascular health, weigh 
practicality of clinical usefulness, and study physiology. Three investigations included in 
this dissertation utilized a variety of vascular function measurements (endothelial function, 
arterial stiffness, and its inverse arterial compliance) to investigate each of these research 
areas (an intervention, clinical feasibility, and physiological responses). Overall, this study 
aimed to demonstrate how vascular function could play a pivotal role in the treatment, 










CHAPTER II. VASCULAR FUNCTIONS: INTERVENTION, CLINICAL UTILITY, AND 
MODULATION WITH FREE DIVING: A LITERATURE REVIEW 
 
Blood Pressure Determinants 
 High blood pressure is a major risk factor for morbidity and mortality worldwide  
(120). Hypertension is defined as a systolic blood pressure ≥130 mmHg and/or diastolic 
blood pressure of ≥80 mmHg (25). Hypertension is a result of physiological, lifestyle and 
genetic factors (112). Unfortunately, more than 90% of hypertension cases are of 
unknown etiology (considered essential or primary hypertension), while the other 10% 
(secondary hypertension) are a result of a condition or disease such as renal, 
cardiovascular, neurological and endocrine diseases (112). Prevention and treatment of 
blood pressure is of paramount importance. A 10-mmHg reduction in systolic blood 
pressure reduces the risk of cardiovascular events by 20%, coronary heart disease by 
17%, stroke by 27%, heart failure by 28%, and all-cause mortality by 13% (40). 
 A sedentary lifestyle has become more prevalent in our industrialized society as 
physical activity has been reduced in many occupations due to automation (19). This 
increased sedentary behavior increases the risk of hypertension,  in general each hour of 
sedentary time results in a 2% increased risk of hypertension (79). During prolonged 
sitting, reductions in metabolic demand and blood flow have been shown to increase the 
accumulation of extravascular fluid in the legs (108) as well as decreased shear stress in 
the superficial femoral artery (26). This reduction in shear stress leads to downregulation 
of nitic oxide resulting in greater vasoconstriction and elevated blood pressure (31). 
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 Additionally, epidemiological and family studies have demonstrated a heritability 
component of blood pressure. For example, genetics play a role in the development of 
hypertension as a family history including both parents and/or grandparents with a history 
of high blood pressure increases individuals’ risk of hypertension (116). Moreover, twin 
studies have shown higher agreement of blood pressure in monozygotic than dizygotic 
twins (42). As much as 30% of blood pressure may be heritable (105), as there are 280 
genetic variants that are associated with risk of high blood pressure (123).   
Ambulatory Blood Pressure Monitoring 
 Ambulatory blood pressure monitoring has become the preferred out-of-office 
measurement as it circumnavigates white coat hypertension and masked hypertension 
(24). Typically, the ambulatory blood pressure device takes blood pressure readings 
every 15–30 min during the daytime and 20–60 min at night. This allows for insight into 
an individual’s blood pressure changes throughout a 24-hour period. Typically, individuals 
who are normotensive have a clear diurnal rhythm of blood pressure, with a substantial 
drop during the first few hours of sleep and a surge upon waking (126). Ambulatory blood 
pressure monitoring can pick up abnormalities such as a diminished drop (<10%) or an 
elevation in blood pressure during sleep. Indeed, individuals with a non-dipping pattern 
are at increased risk for cardiovascular events (119). Similarly, an excessive morning 
surge in blood pressure results in increased risk for adverse events (69). Therefore, 24-
hour ambulatory blood pressure monitoring has been shown to have better prognostic 





 Cardiovascular disease progresses undetected for many years, and the 
endothelium plays a major role in its progression (170). The endothelium was once 
considered nothing more than a permeable membrane between blood flow and the outer 
vascular wall, but it is now considered a critical homeostatic organ for the regulation of 
vascular tone and structure (179). The endothelium is responsible for detecting changes 
in hemodynamics (shear stress and wall strain), regulating vascular tone, growth, 
adhesion, and coagulation (170). Endothelial cells can metabolize L-arginine via 
endothelial nitric oxide synthase to produce nitric oxide. Nitric oxide exerts a 
cardioprotective role by relaxing smooth muscle cells, decreasing leukocyte adhesion and 
migration, muscle cell proliferation, platelet adhesion and aggregation (160). Impairment 
in endothelial function is evident prior to the development of atherosclerosis and may be 
a predisposing factor for the development of hypertension and diabetes (136, 137). 
Additionally, endothelial function measured via flow-mediated dilation has been shown to 
be inversely correlated to the Framingham risk score for cardiovascular disease (184). 
Endothelial dysfunction is also linked to inflammation within atherosclerotic plaques 
increasing the risk for cardiovascular events (4, 52, 135). Thus, endothelial function has 
been included among markers of organ damage in the European hypertension guidelines 
(94).   
Ischemic Preconditioning 
 Ischemic preconditioning (IPC) refers to the phenomenon whereby three or four 
brief periods of ischemia, each followed by tissue reperfusion, confers subsequent 
protection against the magnitude of tissue injury following ischemia (169). Repeated IPC 
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can also exert influence on vascular function and health, and both long-term multiple 
sessions (67, 71) and a single session of IPC enhances endothelial function in humans 
(110). Indeed, a shear stress intervention, in which 5 seconds of brachial occlusion 
followed by 10 seconds of rest for 30 minutes 5 times per week for a total of 6 weeks, has 
been shown to enhance FMD (58). IPC can blunt the myocardial damage following an 
infarction and can reduce the overall amount of damage (125). Seven days of IPC have 
been shown to improve both local and systemic endothelial function and microcirculation 
in healthy young males (67). Furthermore, IPC reduces cardiac cell apoptosis (113), 
myocardial and vascular damage (70). These improvements are seen in both an early (2 
to 3 hours) and late phase (3 to 4 days) (75), with limited evidence showing residual 
effects up to 8 days post IPC (67). Although IPC typically includes repeated bouts of 5 
minutes of ischemia followed by reperfusion, 2 minutes of ischemia and reperfusion is 
sufficient to induce an immediate protective effect (71). In fact, individuals with suspected 
myocardial infarctions can benefit from IPC in the ambulance on the way to the hospital 
by demonstrating better myocardial salvage and decreased adverse cardiac and 
cerebrovascular events over 4 years of follow-up when compared with normative care 
controls (16).  A protective effect of IPC has been demonstrated via decreased troponin 
expression (an indicator for heart muscle damage) following coronary artery bypass graft 
surgery in patients who received IPC for 20 days prior to surgery (81). 
 IPC has an anti-inflammatory effect by reducing neutrophil adhesion to the 
endothelium and increasing interleukin-10 (22, 146). Cardioprotective signaling 
molecules that are released locally during IPC include adenosine, bradykinin, opioids, 
hydrogen sulfide, and nitric oxide (56, 61, 87, 144, 147). These molecules ultimately 
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activate protein kinase C and reperfusion injury salvage kinases, which modulates the 
cardioprotective effects (88). Typically, reperfusion injury limits the production of ATP 
from the mitochondria leading to cell necrosis. These signaling pathways work on the 
mitochondria by activating ATP-dependent potassium channels, which provide 
cardioprotection (56). Moreover, IPC has been shown to increase the expression of 
endothelial nitric oxide synthase mRNA and signal transducer and activator of 
transcription 5 (STAT-3) as well as increase the amount of circulating endothelial 
progenitor cells (81).  
 Ischemia preconditioning is an effective method to protect against ischemia-
induced injury (128). This maneuver of ischemic preconditioning typically involves 3–4 
cycles of 5 min of ischemia followed by reperfusion using a blood pressure cuff. In many 
human cardiovascular research studies, it is common to concurrently measure endothelial 
function and ambulatory (24-h) blood pressure in the same investigation (47, 89, 138). 
The ambulatory blood pressure device takes blood pressure readings every 15–30 min 
during the daytime and 20–60 min at night. Even though the duration of ischemia induced 
by blood pressure measurements is fairly short, repeated episodes of IPC, that is 
“increasing in dose”, may provide potent reductions in ischemic myocardial damage 
(186). Indeed, 2 min of ischemia and reperfusion have been shown to be sufficient to 







Arterial stiffness refers to the material properties of the arterial wall that have 
functional influences over blood pressure, blood flow, and the diameter changes with 
each cardiac cycle. Arterial stiffness can be measured via pulse wave velocity (PWV), 
which is the speed of the forward pressure wave transmitted from the aorta through the 
vascular tree (91). PWV provides a segmental value of arterial stiffness and has been 
validated by the Bramwell Hill equation (18). Arterial stiffness has been shown to provide 
valuable prognostic information for future cardiovascular diseases and events. 
Specifically, a 1 m/s increase in carotid-femoral PWV (cfPWV) is associated with a 7% 
increased risk of cardiovascular events (10). Arterial stiffening increases with advancing 
age (165) and does not seem to be dependent on atherosclerosis (163). With advancing 
age, mechanical fraying of elastin structures within the vascular wall from repeated bouts 
of mechanical stress and crosslinking of collagen fibers from advanced glycation end-
products, leads to increased stiffening of the arteries (74, 77, 180, 189). Moreover, with 
elevated arterial stiffening, pulsatile pressure waves within the blood vessels are 
generated via cardiac contraction and propagates to the peripheral microvasculature, 
resulting in damage (175). Additionally, arterial stiffness contributes to the development 
of hypertension and is an accurate predictor of high blood pressure (174).   
Measurements of Arterial Stiffness 
 There are a number of methods that have been developed to measure arterial 
stiffness. Most of the measurements are based on one of three models developed to 
capture arterial stiffness (164). One of the most common is the transmission/propagation 
model, which utilizes tonometer’s or cuffs to measure the time it takes for a pressure wave 
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to travel from a proximal artery to a distal artery. An example of this measure is cfPWV 
and is often described as the reference standard measure for arterial stiffness with its 
plethora of studies demonstrating clinical evidence that link it to mortality (10). Other 
measurements under this model that are commonly used include brachial-ankle PWV and 
cardio-ankle vascular index. Brachial-ankle PWV is a simplified method in that it uses air 
pressure and a volume plethysmograph (cuff based) to measure the PWV between the 
brachial artery around the upper arm and the ankle. However, brachial-ankle PWV is 
affected by blood pressure (162). Therefore, cardio-ankle vascular index was developed 
to encompass arterial stiffness of the thoracic, abdominal, common iliac, femoral, and 
tibial arteries independent of blood pressure (192), although a recent study has indicated 
that this measure is not truly independent of blood pressure (84). It is calculated using an 
electrocardiogram, phonocardiogram, brachial artery, and ankle artery waveforms by 
measuring PWV via dividing vascular length by the time taken for the pulse wave to travel 
from the aortic valve to the ankles (148, 192).  
 The next model of arterial stiffness is the pulsation or distension model, which 
utilizes ultrasound-derived local artery compliance and distensibility measures. 
Specifically, this measurement relates pressure changes to diameter changes and 
provides local assessments of arterial stiffness with the use of a pressure transducer on 
an artery and ultrasound. Measurements under this model include elastic modulus, 
Young’s modulus, arterial distensibility, and β-stiffness index. Elastic modulus is the 
pressure change required for theoretical 100% stretch from resting diameter. Young’s 
modulus is elastic modulus per unit area. Arterial distensibility is defined as the relative 
increase in diameter for a given increase arterial blood pressure, the inverse of elastic 
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modulus (133). β-stiffness index is the ratio of ln(systolic/diastolic pressures) to relative 
change in diameter (91).  
The last model of arterial stiffness is the Windkessel model (a reservoir that allows 
arterial wall distension that can maintain diastolic pressure and perfusion via elastic recoil 
during diastolic periods), which measures systemic arterial compliance via the area 
method. Systemic arterial compliance is often calculated as the ratio of stroke volume 
divided by pulse pressure (30, 190). 
Clinical Utility and Application of Arterial Stiffness 
 Arterial stiffening of the central arteries results in hemodynamic consequences, 
such as increased pulse pressure, decreased shear stress, and elevated pulsatile flow 
into the microcirculation (176). It has been widely demonstrated that higher cfPWV is 
associated with increased risk of cardiovascular events and their recurrence (10, 183). In 
2007, the European Society of Hypertension and Cardiology proposed a cutoff value of 
12 m/s to be used as an indicator of subclinical organ damage (94), eventually this 
threshold was updated to 10 m/s (178). To measure arterial stiffness in a clinical setting, 
cfPWV could be recommended since it is recommended in multiple populations with 
supporting evidence from randomized clinical trials and meta-analyses (10, 183). 
However, arterial stiffness (cfPWV) has yet to become widely used outside of the 
research setting due to the technical nature of applying the tonometer and acquiring 
quality pressure waves at both the carotid and femoral arteries. PWV measurements of 
other arterial segments such as brachial-ankle PWV or cardio-ankle vascular stiffness 
index have been utilized in Asian populations, although there is a lack of longitudinal 
studies in the United States and Europe. These cuff-based measurements are much 
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easier to use in a clinical setting but currently have less evidence via randomized clinical 
trials and meta-analyses (10).  As such, a new measurement of central arterial stiffness 
using blood pressure cuffs as opposed to tonometers should be developed to make this 
measurement more clinically applicable.  
 Recently, a novel index of arterial stiffness heart-thigh PWV (htPWV) was 
developed to eliminate the placements of transducers on the carotid and femoral arteries 
and to make the measurement substantially easier. The new measurement allows 
noninvasive, minimally intrusive, and user-independent acquisition of central pulse wave 
velocity. However, there is need to validate the agreement with the reference standard 
for arterial stiffness (cfPWV) and the new device before it could be recommended for use 
in a clinical setting, given the potential practicality of implementation for novice users. 
The Diving Reflex 
 The diving reflex is a powerful autonomic response that preserves oxygen and 
maintains blood flow to vital organs that is triggered by apnea and facial immersion in 
cold water (122). It is characterized by bradycardia, decreased cardiac output, peripheral 
vasoconstriction and increased arterial blood pressure (6). The diving reflex was first 
introduced by Edmund Goodwyn in 1786, but its physiological relevance was recognized 
following a publication by the French physiologist Paul Bert in 1870 in his work with ducks 
and other animals during asphyxia (12, 51). The increase in peripheral resistance during 
the diving reflex redistributes blood flow to the vital organs while limiting oxygen 
consumption. Furthermore, bradycardia decreases the work of the heart to further limit 
oxygen consumption. As such, the diving reflex has been described as the “master switch 
of life” (142). Interestingly, the diving reflex is innate in all vertebrates including diving 
12 
 
mammals, reptiles, birds and has been observed even in fish that demonstrate 
bradycardia when removed from water (142).  
 The interacting autonomic control that mediates these cardiovascular responses 
during the diving reflex are complex and are not fully understood. However, it has been 
shown that trigeminal nerve activity, peripheral chemoreceptors, and baroreceptors play 
a major role (54, 85, 124). Additionally, afferent and efferent neuron tracts along with the 
carotid chemoreceptors are important mediators of the reflex (35). The facial immersion 
in cold water triggers a neuronal afferent response from the trigeminal nerve (3). The 
nerve fibers innervating the anterior nasal mucosa and paranasal region are essential for 
this reflex via chemesthetic trigeminal chemoreceptors (103). These afferent neuronal 
signals are transmitted to the brainstem, resulting in efferent neuronal signals that activate 
the sympathetic nervous system (muscarinic M2 receptors) inducing peripheral 
vasoconstriction and parasympathetic nervous system (vagus nerve) eliciting 
bradycardia. The carotid chemoreceptors also help to stimulate bradycardia and 
peripheral vasoconstriction (8). Furthermore, this reflex has been shown to provide 
diagnostic and clinical applications for individuals with vagal dysfunction, diabetic 
cardiovascular autonomic neuropathy, baroreflex impairment, and aroxysmal atrial 
tachycardia (187). Therefore, this section of the literature review discusses the effects of 
free diving and how the diving reflex can be studied to help further our knowledge of the 





Autonomic Control of Circulation During Exercise 
 The autonomic nervous system is responsible for mediating cardiovascular 
adjustments necessary to maintain blood pressure and perfusion to vital organs during 
exercise and strenuous activities such as free diving (46). These cardiovascular 
adjustments are accomplished by the parasympathetic and sympathetic nervous system 
via central command, the exercise pressor reflex, the arterial baroreflex, cardiopulmonary 
baroreceptors, and arterial chemoreceptors (44).  
 Central command encompasses descending neural signals from the higher brain 
center that activates the cardiovascular control center (36, 50), eliciting muscle 
sympathetic nerve activity (17, 50, 117). At the onset of exercise, a reduction in 
parasympathetic activity via the vagus nerve contributes to increases in heart rate (134). 
Additionally, at higher intensity exercise, increases in heart rate and contractility are due 
to increases in cardiac sympathetic activity as well as epinephrine released via the 
adrenal medulla (44). Furthermore, there is functional sympatholysis (attenuated 
vasoconstriction) in the working skeletal muscles and a redistribution of cardiac output to 
these active tissues to supply oxygen and nutrients and clear metabolites (132). 
Additionally, during dynamic exercise, the sympathetic nervous system is an important 
regulatory mechanism for blood pressure responses (29). 
 The exercise pressor reflex demonstrated by the seminal work of Alam and Smirk 
(1937) highlights the importance of afferent feedback from skeletal muscle in elevating 
blood pressure during exercise in humans (1). The exercise pressor reflex is 
encompassed by group III and IV muscle afferents that provide feedback for mechanical 
and chemical stimuli within the contracting skeletal muscle (27, 102). The metaboreflex 
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utilizes acid-sensing ion channel 3 for lactic acid, purinergic 2x receptors for adenosine 
triphosphate, prostaglandin E2 receptor 4 for prostaglandin, and are redundant as a 
combined blockade is required to attenuate the exercise pressor reflex (157). These 
afferents project through the dorsal horn of the spinal cord, then to the ventral lateral 
medulla and the nucleus solitarii (151). Normally, the group III and IV muscle afferents 
contribute to the cardiovascular responses (e.g., heart rate and blood pressure) to 
exercise by increasing their discharge frequency. 
 The arterial baroreflex provides negative feedback that is necessary for regulating 
beat-to-beat blood pressure (45, 99). Specifically, the arterial baroreceptor is a 
neurocardiovascular receptor that is made up of unencapsulated stretch-sensitive nerve 
endings in the carotid sinus bifurcation and aortic arch that transmit neural impulses to 
the central nervous system. Subsequently, these afferent impulses to the central nervous 
system are integrated, and the efferent arm of the reflex projects signals via the 
sympathetic and parasympathetic branches of the autonomic nervous system. When 
blood pressure increases, the stretch-sensitive nerve endings increase their firing rate, 
and efferent sympathetic output is inhibited while parasympathetic output increases (109). 
 The cardiopulmonary baroreflex is made up of mechanically sensitive receptors in 
the heart, lungs, and great veins that provide feedback to the medullary vasomotor 
centers through unmyelinated vagal afferents (96, 182). They respond to changes in 
central venous pressure and volume (93). Although the role of the cardiopulmonary 
baroreflex is not completely understood, it does play a functional role during exercise by 
attenuating sympathetic input. For example, the inhibition of muscle sympathetic nerve 
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activity during exercise may be a result of increased venous return and elevations in 
central venous pressure, which stimulates the cardiopulmonary baroreceptors (44). 
 The arterial chemoreflex is made up of chemically sensitive receptors in the carotid 
bodies and aortic bodies (98). They sense chemical changes in the bloodstream and send 
afferent signals to the medullary regions via the carotid sinus and vagus nerve, which 
help provide respiratory and autonomic control (104). The chemoreflex can restrain 
exercising blood flow by causing vasoconstrictor sympathetic outflow to skeletal muscle 
during acute hyperoxia (156).  
Free Diving (Diving Mammals and Humans) 
 In the world’s largest animal, the blue whale (Balaenoptera musculus), heart rate 
decreases from 15 bpm to as low as 2 bpm during diving (49). Moreover, their heart rate 
is only half the resting value during highly metabolic maneuvers (e.g., lunge feeding) (49). 
This is possible due to their extremely compliant aortic arch that acts as a Windkessel 
(the compliant aorta acts a reservoir during systole) and maintains blood flow during 
extreme bradycardia and reduces pulsatility of blood flow into the distal aorta (82). The 
aortic arch that acts as a Windkessel allows arterial wall distension that is capable of 
maintaining diastolic pressure and perfusion to the coronary arteries via elastic recoil 
during extended diastolic periods (118). Other diving mammals such as the Weddell seal 
(Leptonychotes weddellii) are capable of diving for longer than an hour. The diving reflex 
stimulus is strong enough to cause bradycardia for the duration of the dive even during 
intense exercise (142). In contrast to the effects on heart rate, the effect of submersion 
on stroke volume in diving mammals have been somewhat inconsistent. For example, 
some studies demonstrated that stroke volume remains consistent during forced or 
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trained submersion (15) while others report that stroke volume is decreased by up to 50% 
(37, 153, 193). In trained harbor seals (Phoca vitulina) during voluntary diving at moderate 
to high intensity exercise, stroke volume has been shown to decrease when compared 
with the resting value at the surface (127). Stroke volume likely declines due to decreased 
venous return and cardiac filling and decreased ejection fraction as a result of reduced 
inotropy (decreased myocardial contractility) (39, 72).  
 In humans, free diving activities (apnea-related sports) include spearfishing, 
underwater photography, underwater hockey and rugby, underwater target shooting and 
synchronized swimming. Free diving requires the capability to suppress the urge to breath 
and involves prioritizing blood flow to the brain and heart while using the available oxygen 
as efficiently and sparingly as possible. Free diving in humans, such as the Japanese 
female pearl divers called Ama have been diving for seaweeds, shellfish and pearls off 
the coast of Japan for over 2000 years (60). Ama perform over 100 breath-hold repeated 
diving maneuvers on a daily basis and continue this tradition into old age (149). Recent 
studies have aimed to determine whether such substantial stimulus resulted in structural 
and functional changes in this diving population (159, 168). Indeed, Ama demonstrate 
reduced systemic arterial stiffness than age-matched sedentary peers (168). Additionally, 
they also have lower arterial stiffness in more proximal and elastic arterial regions, 
indicating that Ama have superior reservoir function of the proximal aorta and carotid 
artery when compared with age-matched sedentary controls from the same region (159). 
This increased compliance of the aorta is necessary to buffer elevated cardiac pulsations 
during diving maneuvers.  
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 The cardiovascular responses to diving have previously been studied in laboratory 
settings. Interestingly, the diving reflex elicits greater bradycardia during dynamic 
exercise than at rest (11). A study utilizing face immersion, apnea and exercise on a cycle 
ergometer demonstrated reductions in heart rate and cardiac output and increased 
systemic vascular resistance in humans, which is a similar response observed in seals 
(13). Furthermore, these cardiovascular responses during simulated diving have 
augmented responses in trained divers when compared with non-diver controls (171). 
Collectively, these studies support the notion that the diving reflex is powerful enough to 
override sympathetic activity from exercise stimulus. However, a recent study measured 
cardiovascular responses of free divers in the open sea that went to depths up to 30m 
and revealed that simultaneous activation of exercise (dynamic phases of diving) and the 
diving reflex led to an absence of cardiac output reduction to conserve oxygen due to 
increased stroke volume and only decreased heart rates during resting phases of the dive 
(97). The authors speculate that the sympathetic discharge during the dynamic phases 
of the dive overrode the parasympathetic activity. 
Individual Components Involved in Free Diving 
 Apnea. The major physiological response allowing vertebrates to endure a lack of 
oxygen is the diving reflex (46). Apnea is sufficient stimulus to trigger a decrease in heart 
rate, although bradycardia is blunted during apnea alone when compared with facial 
immersion and apnea together (143, 158). During breath holding, there is increased 
anaerobic metabolism as increases in plasma lactate concentration are observed (6). 
During apnea, there is also reduced oxygen uptake from the lungs to the blood, thereby 
conserving lung oxygen reserve (86). Additionally, during breath holding, spleen volume 
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decreases around 20% resulting in increased hematocrit and hemoglobin in the blood to 
enhance oxygen transport (9). Interestingly, chronic free divers known as Sea Nomads 
from South East Asia have larger spleen sizes compared to their closest geographic 
neighbors, the Saluan (62). Moreover, apneic divers with the highest scores (longer 
breath hold times) have larger spleen volumes when compared to those with lowest 
competition scores (140). 
 Chemoreceptor Stimulation. The carotid body is composed of glomus cells that 
are chemosensitive and type II cells that play a glial-like role as well as a carotid sinus 
afferent nerve (48). The carotid body detects and elicits responses to hypoxia to maintain 
arterial blood pH and partial pressure of carbon dioxide (34). Specifically, these 
responses include bradycardia, vasoconstriction, and secretion of catecholamines (28, 
66). Hypoxia is a necessary stimulus for chemoreceptors to aid in the diving reflex 
bradycardia, while hypercapnia can attenuate this bradycardia response (85).  
 Lung Volume. The diving reflex is also modulated by pulmonary stretch receptors 
by changes in intrapleural pressure and lung volume. For instance, the cardiovascular 
adjustments that occur during apnea are attenuated by excitation of pulmonary stretch 
receptors (65). Typically, heart rate increases during inspiration due to parasympathetic 
withdrawal and decreases during expiration with increased parasympathetic tone (28).  
During diving, bradycardia is greatest with smaller lung volumes due to a decrease in 
pulmonary stretch receptor activity (7). Indeed, increased hydrostatic pressure with water 
immersion has been shown to decrease total lung capacity (20). Moreover, heart rate 
decreases more when lung volumes are held at 60% when compared with 85% of vital 
capacity (5). This may be a result of smaller lung volumes having minimal stretch receptor 
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activity. Alternatively, increased intrathoracic pressure is associated with the greater lung 
volume (85% compared to 60% of vital capacity), thereby inhibiting venous return that 
reduces stroke volume and causes elevated heart rate (131).  
 Respiratory Neuronal Drive. The diving reflex bradycardia is affected by the drive 
to breathe. Specifically, respiratory drive inhibits carotid body activity from stimulating 
cardiac vagal activity (38).  Breath holding acts to simulate the respiratory neuronal drive 
possibly by inhibiting feedback from the pulmonary stretch receptors, or when muscle 
spindle afferents are activated when respiratory muscles fail to shorten (185). 
Additionally, face immersion in cold water reduces the respiratory neuronal drive (111). 
However, the drive to breathe eventually overcomes this inhibition and results in 
involuntary respiratory contractions (185).  
 Muscle Sympathetic Nerve Activity. During diving, facial cold receptors’ input 
and chemoreceptor stimulation modulate sympathetic nerve activity (155). Facial 
immersion in cold water triggers muscle sympathetic nerve activity but not with warm 
water (41). Moreover, hypoxia using breath-holding with 10% oxygen results in greater 
muscle sympathetic nerve activity than when breath holding with 100% oxygen or room 
air (80). Additionally, the anticipation to dive increases skin sympathetic nerve activity 
(41). Chemoreceptor stimulation also helps to cause peripheral vasoconstriction and 
increases muscle sympathetic nerve activity (155).  
Arterial Compliance 
 Increased arterial compliance is necessary to buffer elevated cardiac pulsations 
during diving maneuvers (159). It has been demonstrated that blood flow in the carotid 
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artery is increased during breath-holding and diving (121). This blood flow redistribution 
via peripheral vasoconstriction during diving maneuvers ensures the availability of oxygen 
to the brain (121). Moreover, cerebral blood flow is substantially increased during facial 
immersion in cold water (73). Additionally, apnea augments pial artery pulsations but 
appears to be independent of cardiac changes indicating a protective mechanism for 
perfusion to the brain (188). Indeed, free divers coping mechanism against hypoxia is a 
substantial increase in cerebral blood flow, suggesting cerebral autoregulation is 
compromised to sustain brain function (181). With increases in arterial pressure and 
increased perfusion to the brain, it is feasible to speculate that carotid artery compliance 
is augmented to help buffer these elevated cardiac pulsations during diving maneuvers.  
 In addition to the diving reflex that is triggered by facial immersion in cold water 
(122), diving maneuvers are accompanied by apnea and exercise. Each of these stimuli 
have varying influences on the cardiovascular responses that occur during the diving 
maneuver. The degrees of diving bradycardia and hypertension induced by the diving 
reflex are fairly substantial in spite of the vigorous underwater swimming performed by 
sea divers (97). During free diving, mean arterial pressure has been shown to increase 
from 96 to 113 mmHg (97). This condition provides a circulatory challenge to properly 
buffer and cushion cardiac pulsations. Therefore, with increased blood pressure during 
diving maneuvers, carotid artery compliance may be augmented to help buffer these 
elevated cardiac pulsations. However, prior to this study, the hemodynamic changes that 






 Each of the three aims discussed above utilize measures of vascular function to 
evaluate varying research topics. Specifically, this dissertation study investigated an 
intervention in which ambulatory blood pressure monitoring may act as ischemia 
preconditioning to enhance endothelial function, evaluated the clinical feasibility of a novel 
nontechnical measure of central arterial stiffness by comparing its agreement to the 
reference standard, and studied the cardiovascular responses that occur during the diving 
reflex to further understand how vital organs maintain perfusion. Taken together, these 






CHAPTER III. STUDY 1: DOES 24-H AMBULATORY BLOOD PRESSURE 
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Purpose: Ischemic preconditioning can exert a powerful protection against a 
subsequent period of ischemia, via repeated inflation and deflation of a blood pressure 
cuff. Most often, damages of ischemia-reperfusion injury and benefits of preconditioning 
are evaluated via endothelial function. The ambulatory blood pressure monitoring 
constitutes repeated bouts of ischemia for 24 h. We examined whether repeated bouts of 
ischemia accumulated over 24 h influenced endothelial function. Methods: Twenty-two 
apparently healthy non-medicated middle-aged subjects 41 ± 8 years participated in the 
study. This study was registered with ClinicalTrials.gov (NCT03303404). Flow-mediated 
dilation (FMD) was measured as an index of endothelium-dependent vasodilation. 
Results: The ambulatory blood pressure monitoring device went through an average of 
110 ± 13 inflation/deflation cycles, which resulted in 46 ± 6 min of cumulative ischemic 
stimuli. Following 24-h of ambulatory blood pressure monitoring, FMD did not change 
significantly 6.6 ± 2.0 vs. 6.8 ± 2.7%. Similarly, shear rate and reactive hyperemia were 
unchanged. Conclusion: We concluded that ambulatory blood pressure monitoring did 










 Reestablishing blood flow to ischemic organs causes endothelial dysfunction 
leading to ischemia-reperfusion injury and tissue death. This so-called ischemia-
reperfusion injury can be attenuated or prevented by preceding brief periods of ischemia, 
each followed by tissue reperfusion (169). This maneuver is referred to as ischemic 
preconditioning (IPC) and typically involves 3-4 cycles of 5 min of ischemia followed by 
reperfusion using a blood pressure cuff. In many human cardiovascular research studies, 
it is common to concurrently measure endothelial function and ambulatory (24-h) blood 
pressure in the same investigation (47). The ambulatory blood pressure device takes 
blood pressure readings every 15-30 min during the daytime and 20-60 min at night. Even 
though the duration of ischemia induced by blood pressure measurements is fairly short, 
repeated episodes of IPC, that is “increasing in dose”, may provide potent reductions in 
ischemic myocardial damage (186). Indeed, 2 min of ischemia and reperfusion have been 
shown to be sufficient to induce an immediate protective effect (172). In addition, a shear 
stress intervention, in which 5 s of brachial occlusion followed by 10 s of rest for 30 min, 
five times per week, for 6 weeks enhanced flow-mediated dilation (FMD) in healthy males 
(58).  
Prior to this study, there was no information available as to whether ambulatory 
blood pressure monitoring could induce preconditioning effects and increase endothelial 
function via repeated bouts of inflation/deflation cycles. As such, we hypothesized blood 






Twenty-two apparently healthy normotensive middle-aged participants came to the 
laboratory following an overnight fast, participant demographics are presented in Table 
1. Prior to testing, participants gave their written informed consent and completed a health 
history questionnaire. Participants were excluded from the study if they were pregnant, 
had a recent illness, history of diabetes, heart disease, or other cardiovascular problems, 
recent surgery, or any other medical intervention. Using the medical history questionnaire 
our participants reported an average of 2 ± 1 risk factors, including age, family history, 
smoking, blood pressure, total cholesterol, physical inactivity, psychological stress, high-
fat diet, and overweight/obesity. All subjects gave their written informed consent prior to 
study participation, and the ethics committee of The University of Texas at Austin 
approved all procedures. This study was approved by the local IRB and registered with 
ClinicalTrials.gov (NCT03303404). 
After 20 min of supine rest, endothelial function was assessed using flow-mediated 
dilation (FMD; index of endothelium-dependent vasodilation) (32). After another 20 min 
of rest, a second measure of endothelial function was performed. These two 
measurements were used to establish repeatability of endothelial function within the 
laboratory. For the data analyses, only the second measurement of FMD was used as 
the baseline (pre) measure of endothelial function. Following these procedures, the 
participants were given an ambulatory blood pressure monitoring device. After 24-h, 
participants returned to the laboratory, and their endothelial function was reevaluated 
following 20 min of rest. 
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Flow-mediated dilatation was measured with a semiautomated diagnostic 
ultrasound system (UNEX-EF38G, UNEX Corporation, Nagoya, Japan) while participants 
rested in a supine position (173). A blood pressure cuff was placed on the forearm with 
the proximal edge of the cuff below the participant’s antecubital fossa. The cuff was 
inflated to 50 mmHg above resting systolic blood pressure for 5 min to occlude blood flow. 
The position of the probe was marked on each participant to ensure subsequent 
measurements were taken on the same region of the brachial artery. Shear rate (s−1) was 
calculated by the following equation: 8 × blood flow velocity (m s−1)/internal artery 
diameter (53). 
Ambulatory blood pressure monitoring provides an insight into blood pressure 
changes in everyday life and an estimate of the overall blood pressure load exerted on 
the cardiovascular system over 24 h (126). Blood pressure recordings were made using 
a noninvasive ambulatory monitor (Spacelabs 90227, Spacelabs Healthcare Inc., 
Redlands, Washington, USA) (90). Participants’ arm circumferences were measured to 
determine appropriate blood pressure cuff sizes; 24–32 cm for adult, 32–42 cm for large 
adult, and 38–50 cm for extra-large adult cuffs. The cuff was programmed to inflate 
automatically to 170 mmHg every 15 min from 6 a.m. to 11 p.m. and every 20 min 
between 11 p.m. and 6 a.m. Physical activity was monitored using a pedometer, which 
was attached to a belt around the participant’s waist. (OMRON HJ-320, OMRON 
Healthcare Inc., Hoffman Estates, Illinois, USA). The cumulative ischemic stimuli from the 
ambulatory blood pressure monitoring were calculated by recording the average time the 
cuff was inflated above the participant’s systolic blood pressure and then multiplied by the 
number of measurements taken. 
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Statistical analyses were performed with GraphPad Prism (version 7.05, San 
Diego, California, USA). Data were first tested for the normal distribution. Statistical 
significance before and after ambulatory blood pressure monitoring for FMD, and blood 
flow responses were evaluated by the Student’s t-tests for paired data. A post hoc power 
analysis was conducted using the program G*Power (version 3.1.9.2). Considering the 
difference between the mean and standard deviation (Pre to Post) with an alpha level of 
0.05 for FMD in response to ABPM, the overall sample size of 22 participants in this study 















Table 1. Participant Characteristics   
Variable Means ± SD   
Age, years 41 ± 8   
Males/Females, n 12 M / 10 F   
Height, cm 170 ± 10   
Body weight, kg 74 ±17   
BMI, kg/m
2 25 ± 4   
Heart rate, bpm 71 ± 9   
Systolic BP, mmHg 121 ± 24   
Diastolic BP, mmHg 74 ± 12   
Mean BP, mmHg 89 ± 14   
PP, mmHg 47 ± 14   
PA, steps 7620 ± 2473   
MVPA, bouts/week 4 ± 2   
BMI = body mass index; BP = blood pressure; 
PP= pulse pressure; PA = physical activity; 















The ambulatory blood pressure monitoring device went through an average of 110 
± 13 inflation/deflation cycles. Due to erroneous readings, there were an average of 13 ± 
6 re-measures. Which resulted in 46 ± 6 min of cumulative ischemic stimuli. Average 24-
h systolic and diastolic blood pressure were 121 ± 24 and 74 ± 12 mmHg. The repeated 
baseline FMD measurements coefficient of variation was 6 ± 9%. We demonstrated FMD 
6.6 ± 2.0 vs. 6.8 ± 2.7% was not significantly increased following 24-h of ambulatory blood 
pressure monitoring (p = 0.57) (Figure 1). Similarly, shear rate 88 ± 51 vs. 84 ± 66 s−1 






























Figure 1. Brachial artery flow-mediated dilation (panel A), shear rate (panel B), and 
reactive hyperemia (panel C) before (Pre) and after (Post) 24-hour ambulatory blood 



































































 The purpose of this study was to determine the influence of 24-h ambulatory blood 
pressure monitoring on endothelial function. We demonstrated that FMD, shear rate, and 
reactive hyperemia were not influenced by the 24-h ambulatory blood pressure monitoring 
stimuli. 
 The present study findings have at least two important implications. First, the 46 ± 
6 min of cumulative ischemia via 24-h of blood pressure monitoring in the present study 
was not sufficient to produce significant changes in endothelium-dependent vasodilation 
in middle-aged adults. A recent shear stress intervention, involving 5 s brachial occlusion, 
10 s rest for 30 min, five times weekly for 6 weeks, enhanced endothelial function (32). In 
addition, an ischemia preconditioning intervention over two weeks resulted in a robust 
2.2% increase in FMD (68). A cuff around the upper arm was inflated to 220 mmHg for 5 
min using a rapid inflator to produce an ischemia stimulus, and then deflated to allow 
reperfusion for 5 min. This cycle was repeated four times per episode (68). The pattern 
of ischemic stimulus we used might account for the unchanged FMD in the present study. 
In addition, IPC has been shown to have ‘early’ and ‘late’ phases of protection. Indeed, 
the previous study observed improvements in FMD during the late phase (68). Our study 
probed for improvements in endothelial function immediately within the early stage of 
protection. Thus, future studies are needed to determine if repeated bouts of ambulatory 
blood pressure monitoring can modulate endothelial function, as clinical benefits of IPC 
are becoming evident (169). Second, many cardiovascular research laboratories 
measure 24-h ambulatory blood pressure monitoring and FMD in tandem in the same 
study (47). Accordingly, it would be of particular interest if 24-h of ambulatory blood 
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pressure monitoring would influence endothelial function via ischemic preconditioning. In 
the present study, we did not observe any interference between the measurements. In 
addition, it should be noted that our findings are limited to apparently healthy adults. As 
such, future studies are needed to address whether ambulatory blood pressure 
monitoring stimuli can modify endothelial function in clinical populations. 
 In conclusion, the present study showed that 24-h of ambulatory blood pressure 
monitoring did not influence endothelial function acting through ischemic preconditioning. 
Thus, 24-h ambulatory blood pressure monitoring and FMD would be measured in 














CHAPTER IV. STUDY 2: HEART-THIGH CUFF PULSE WAVE VELOCITY: A NOVEL 
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Purpose: Recently, a novel index of arterial stiffness was developed to eliminate 
the placements of transducers on the carotid and femoral arteries and to make the 
measurement substantially easier. We evaluated the agreement of this new methodology 
with the well-established carotid–femoral pulse wave velocity (cfPWV). Methods: A total 
of 50 adults (28 men and 22 women) varying widely in age and blood pressure were 
studied. Heart-thigh pulse wave velocity (htPWV) and cfPWV were measured and 
compared. Results: Mean values of cfPWV and htPWV were 713 ± 145 and 699 ± 150 
cm/s and were not significantly different (P = 0.43). Both cfPWV and htPWV were 
significantly associated with age (r = 0.80 and 0.58), body mass index (r = 0.44 and 0.31), 
and systolic blood pressure (r = 0.42 and 0.41). Conclusion: The two pulse wave velocity 
measures demonstrated a strong linear association with a Pearson correlation coefficient 
of 0.64 (P < 0.001). This agreement was consistent with the results of the Bland–Altman 
plot. The automatic htPWV method, which permits the data acquisition with minimum 
technical skill, time, and intrusion in an operator independent fashion, has potential as a 









 Arterial stiffness is a major contributor to cardiovascular disease and is an 
important element for risk stratification (10). Given the substantial emphasis placed on 
primary and secondary prevention of cardiovascular disease, a number of noninvasive 
techniques have been developed to assess vascular stiffening (83, 164). Among them, 
carotid–femoral pulse wave velocity (cfPWV) has been considered a reference standard 
measure of arterial stiffness because of the accumulated clinical data and strong 
associations with a variety of disease states (10). However, this technique requires 
operator skills to acquire high-fidelity pulse waves on the carotid and femoral arteries as 
well as the exposure of femoral artery near the groin. Presently, this technique has not 
been used in routine clinical settings and remains only in the clinical research domain.   
Recently, a novel index of arterial stiffness was developed to eliminate the 
placements of transducers on the carotid and femoral arteries and to make the 
measurement substantially easier. The new device allows noninvasive, minimally 
intrusive, and user-independent acquisition of pulse wave velocity. The primary purpose 




 A total of 50 adults (28 men and 22 women) varying widely in age (18–78 years) 
and systolic blood pressure (98–166 mm Hg) were studied (Table 2). Participants who 
had apparent cardiovascular disease were excluded from the study by using a health 
history questionnaire. All participants gave their written, informed consent to participate 
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in the study. All procedures were reviewed and approved by The University of Texas at 
Austin’s Institutional Review Board. 
 The order of the pulse wave velocity recordings was randomized to account for 
any potential interference between the two measures. cfPWV was obtained using an 
automatic vascular screening device (VP-1000 Plus, Omron Healthcare, Kyoto, Japan) 
as previously described (167). Briefly, carotid and femoral arterial pressure waveforms 
were acquired by applanation tonometry sensors attached on the right common carotid 
artery (via neck collar) and right femoral artery (via elastic tape around the hip). The 
distance between common carotid artery and the suprasternal notch was subtracted from 
the carotid–femoral length. 
 Heart-thigh pulse wave velocity (htPWV) was measured with the automated 
vascular screening device (Vasera, Fukuda Denshi, Tokyo, Japan) (100) modified for the 
measurement of htPWV. A segmometer was used to measure the two major segments 
of the body for htPWV length (i) from the left sternal border of the second intercostal space 
to the right femoral artery pulsating site (ii) from the right femoral artery to the center of 
the thigh cuff. The participants rested in a supine position for at least 10 minutes with the 
deflated blood pressure cuffs placed on upper arm and upper thigh. In addition, 
electrocardiogram and phonocardiogram were monitored during this resting period. 
htPWV was calculated as Lht/(Tb + Tbt), where Lht is the body surface distance from 
heart to thigh cuff, Tb is the time delay between the second heart sound on 
phonocardiogram and dicrotic notch on the brachial waveform, and Tbt is the time delay 
between brachial artery and thigh cuff pulse. In this device, Tb was measured from the 
time delay between the second heart sound and the dicrotic notch at the brachial artery 
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under the assumption that these Tb delays are equivalent (161). The foot of the femoral 
and brachial pulses was detected using the volume displacement waveform measured by 
two cuffs placed around the upper thigh and proximal to the antecubital fossa, 
respectively. 
 Data analyses were performed using the Statistical Package for the Social 
Sciences version 22 (SPSS, IBM Corp., Armonk, NY). Statistical differences between 
different methods were evaluated by the Student’s t-tests for paired data. Associations of 
interest were analyzed by Pearson correlational analyses and stepwise regression 
analyses. The statistical procedure proposed by Bland and Altman was used to compare 
two different methods (14). First, the correlation and regression analyses were conducted 
between measured values. The initial step served as the evaluation of the degree of 
agreement between the two methodologies. Second, the relative differences within each 
pair of measurements were plotted against the mean of the pair. A p value < 0.05 was 










Table 2. Participant Characteristics 
Variable Means ± SD   
Age, years 34 ± 16  
Males/Females, n 28 M / 22 F  
Height, cm 171 ± 10  
Weight, kg 73 ±15  
BMI, kg/m2 25 ± 4  
Systolic BP, mmHg 121 ± 13  
Mean BP, mmHg 88 ± 9  
Diastolic BP, mmHg 72 ± 8   
















 Mean ± SD age, height, body weight, body mass index, and systolic/diastolic blood 
pressure of the participants were 34 ± 16 years, 171 ± 10 cm, 73.3 ± 15.0 kg, 24.9 ± 4.0 
kg/ m2, and 121 ± 13/72 ± 8 mm Hg, respectively (Table 2). Mean values of cfPWV and 
htPWV were 713 ± 145 and 699 ± 150 cm/s and were not significantly different (P = 0.43). 
The mean ± SD difference between the two methods was 14 ± 125 cm/s. Both cfPWV 
and htPWV were significantly associated with age (r = 0.80 and 0.58), body mass index 
(r = 0.44 and 0.31), and systolic blood pressure (r = 0.42 and 0.41) (all P < 0.05). Stepwise 
regression analyses revealed that the strongest correlate for both cfPWV and htPWV was 
age, explaining 64% and 34% of the respective variances. The two PWV measures 
demonstrated a strong linear association with a Pearson correlation coefficient of 0.64 (P 
< 0.001) (Figure 2; panel A) although the regression line deviated from the line of identity. 


















Figure 2. Association between carotid-femoral pulse wave velocity (cfPWV) and heart-
thigh pulse wave velocity (htPWV).  Pearson correlational analysis is shown in panel A 










 In the present study, the novel automatic device for measuring arterial stiffness 
(htPWV) was evaluated by comparing it with the reference standard measure of arterial 
stiffness using cfPWV. The significant correlation and the small mean differences 
observed in the Bland–Altman plot reflect a good agreement between the two methods. 
These results suggest that the automatic noninvasive method, which permits the data 
acquisition with minimum technical skill, time, and intrusion in an operator-independent 
fashion, has potential as a screening device for assessing arterial stiffness. 
 Despite the accumulating evidence indicating the clinical importance of arterial 
stiffness, this measure has not been incorporated widely in the routine clinical settings. 
For the measure to be widely adopted, the device would likely need to be straightforward 
to set-up. The novel device evaluated in the present study uses a combination of 
electrocardiogram and phonocardiogram to represent the proximal pulse wave. In the 
cfPWV measurement, the proximal pulse wave is acquired via proper applanation of the 
carotid artery, which requires technical skills and is often difficult to obtain in some 
participants including those who are obese. In addition, the use of a thigh cuff and the 
oscillometric method eliminate the exposure of the inguinal area and the subsequent 
application of a pressure transducer on the femoral artery. This novel technique is easy, 
quick, and operator independent. 
 Although htPWV assessed in the present study is significantly associated with 
cfPWV, the regression line deviated from the line of identity. Similarly, the correlation with 
age was much higher with cfPWV (r = 0.80) than with htPWV (r = 0.58). This may be likely 
due to the use of thigh cuff to measure femoral pulse waves as this has been reported in 
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the cuff-based approaches (21, 57). Indeed, when we measured heart-femoral PWV, 
rather than heart-thigh PWV using the femoral transducer, the correlation with cfPWV 
was much stronger at r = 0.89 (data not shown). In addition, heart-femoral PWV was 
associated with age (r = 0.83) similar to cfPWV. Nevertheless, the present results indicate 
a close association with the reference standard measure of arterial stiffness (cfPWV) and 
















CHAPTER V. STUDY 3: SIMULATED FREE DIVING: INTERACTION OF EXERCISE 





















Purpose: Free diving evokes a complex cardiovascular response and is 
accompanied by apnea and exercise. The degrees of diving bradycardia and 
hypertension induced by the diving reflex are substantial despite the vigorous underwater 
swimming. This condition provides a circulatory challenge to properly buffer and cushion 
cardiac pulsations. We determined hemodynamic changes that occur in the vasculature 
during the diving maneuver. Methods: A total of 20 apparently healthy young participants 
(26 ± 3 years; 10 men and 10 women) participated in this study.  Carotid compliance and 
hemodynamics were measured during apnea, face immersion in cold water (10°C) and 
simulated free diving by having participants perform face immersion in cold water while 
exercising on a cycle ergometer. Results: Simulated free diving resulted in bradycardia 
(p<0.001), increased mean arterial blood pressure (p<0.001), increased total peripheral 
resistance (p<0.001), increased arterial compliance (p=0.007), increased carotid blood 
flow velocity (p<0.001), as well as decreased cardiac output (p<0.001), and decreased ß-
stiffness index (p<0.001). Conclusion: Carotid arterial compliance is augmented during 










 Free diving evokes a complex cardiovascular response known as the diving reflex 
that is initiated by cold water immersion. The diving reflex is characterized by bradycardia, 
decreased cardiac output, peripheral vasoconstriction, and increased arterial blood 
pressure (6). The respiratory physiologist Scholander famously termed this powerful 
response as “the master switch of life” that acts to preserve oxygen and maintain 
perfusion to vital organs (142).  
The degrees of diving bradycardia and hypertension induced by the diving reflex 
are fairly substantial in spite of the vigorous underwater swimming performed by sea 
divers (97). For example, blood pressure has been recorded to reach values as high as 
280/200 mmHg (systolic/diastolic) while free diving due to the associated peripheral 
vasoconstriction and hydrostatic pressure (43). This condition provides a circulatory 
challenge to properly buffer and cushion cardiac pulsations. The central elastic arteries 
play an important role in the compliance function. In fact, diving mammals (e.g., seals, 
sea lions, whales) have a well-adapted arterial structure with substantially larger 
ascending aorta relative to the descending or thoracic aorta to help buffer cardiac 
pulsations and maintain perfusion during substantial bradycardia due to vagal stimulation 
that occurs with the diving reflex (145). Additionally, professional Japanese female pearl 
divers (Ama) demonstrate lower systemic arterial stiffness and superior reservoir function 
in central elastic arteries (159, 168).  
The hemodynamic changes that occur in the vasculature during the diving 
maneuver have not yet been extensively investigated because the diving maneuver 
evokes very complex physiological responses. In addition to the diving reflex that is 
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triggered by facial immersion in cold water, diving maneuvers are accompanied by apnea 
and exercise. Each of these stimuli have varying influences on the cardiovascular 
responses during the diving maneuver (46). Blood flow velocity in the carotid artery is 
increased during the diving reflex (121). Additionally, middle cerebral artery blood flow 
velocity increases with facial cooling and apnea (2). Currently, there is no information 
available regarding how arterial compliance changes in response to diving maneuver as 
well as components of diving maneuver including apnea, face immersion, and exercise. 
Therefore, the purpose of this study was to comprehensively determine the 
cardiovascular responses that occur during the simulated free diving. We hypothesized 
that carotid arterial compliance would be augmented during the simulated free diving 
(diving reflex with exercise) when compared to exercise, apnea, and facial immersion 
individually to help buffer cardiac pulsations.  
 
METHODS 
 Twenty apparently healthy young participants participated in this study (Table 3). 
Participants came to the laboratory on two occasions. Participants submitted their 
informed consent and completed health history questionnaire when first arriving to the 
laboratory. Health status and lifestyle habits of the participants were obtained using the 
Health Research Questionnaire. Then participants had their height and body weight 
recorded. The first visit was used as a familiarization session as a combination of apnea, 
face immersion, and exercise was very challenging.  During the second visit, following a 
4 hour fast, data collection was conducted. After at least 15 minutes of supine rest, arterial 
stiffness was assessed. Afterwards, participants were transferred to the cycle ergometer 
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and carotid arterial compliance, heart rate, blood pressure, and cardiac output were 
measured for 20 seconds at rest. We then measured arterial and cardiac functions during 
the conditions of exercise, apnea, face immersion in cold water (10°C) without apnea 
(using a snorkel device), and simulated free diving, all during steady state exercise for 20 
seconds. Specifically, we combined all the conditions to simulate free diving by having 
participants perform face immersion in cold water with apnea while exercising on a cycle 
ergometer with simultaneous measurements of their cardiovascular responses. 
Specifically, to simulate the diving reflex in the laboratory setting, participants were placed 
on a cycle ergometer and maintained exercise at a light to moderate intensity (25-50 W) 
while holding their breath (for 20 seconds) with facial immersion in cold water (10°C). 
These parameters were based on pilot testing, as trained divers have been shown to 
exercise at 80 W with breath holds of 40 seconds as previously described (6). Participants 
completed each condition (exercise alone [EX], apnea with exercise [EX+A], facial 
immersion while breathing using a snorkel and exercise [EX+FI], and simulated free 
diving, which included facial immersion with apnea and exercise [EX+A+FI]) with 
simultaneous measurements of carotid diameter and pressure, blood pressure, heart 
rate, oxygen saturation, cardiac output, and total peripheral resistance responses being 
recorded for 20 seconds after steady state exercise was reached prior to the beginning 
of each experimental condition. Participants were allowed to rest for up to 5 minutes 
between each condition. On average, each condition was preceded by about 5 minutes 
of exercise to allow heart rate and blood pressure to reach steady state. All procedures 




 Arterial stiffness was measured as previously described in our laboratory (83). 
Briefly, cardio-ankle vascular index (CAVI) and heart-thigh (htPWV) pulse wave velocity 
were measured using an automated vascular screening device (Vasera, Fukuda Denshi, 
Tokyo, Japan). Blood pressure cuffs were applied to the ankles, thighs, and upper arms. 
CAVI is calculated using an electrocardiogram, phonocardiogram, brachial artery, and 
ankle artery waveforms by measuring PWV via dividing vascular length by the time taken 
for the pulse wave to travel from the aortic valve to the ankles (148, 192). CAVI was 
calculated by incorporating the stiffness parameter β, which has been reported to be a 
blood pressure-independent measure of arterial stiffness.  
 Arterial compliance was measured noninvasively during each condition as 
previously described in our laboratory (139). Carotid artery diameter was measured from 
images derived from an ultrasound machine (iE33 Ultrasound System, Phillips, Bothel, 
WA) equipped with a high-resolution linear-array transducer using duplex mode. A 
longitudinal image of the cephalic portion of the common carotid artery was acquired 1–
2 cm proximal to the carotid bulb with the transducer placed at 90° to the vessel. Doppler 
ultrasound was used to acquire blood flow velocity in the carotid artery with an insonation 
angle of 60 degrees. The carotid diameters were measured utilizing automated image 
analysis software (Carotid Analyzer, Medical Imaging Applications, Coralville, IA). Arterial 
pressure waveforms were obtained using an arterial tonometry placed on the contralateral 
carotid artery and recorded on a data acquisition software (Windaq 2000, Dataq 
Instruments, Akron, OH). Carotid artery compliance, cross-sectional compliance, 
distensibility coefficient, ß-stiffness index, and carotid pulse wave velocity were calculated 
as previously described (33, 177). 
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 Arterial blood pressure and heart rate responses were measured continuously and 
noninvasively using the PortaPres finger plethysmograph device (Finapres Medical 
Systems BV, Amsterdam, Netherlands) as previously described by our laboratory (106). 
Specifically, systolic, diastolic and mean blood pressure were measured continuously 
throughout the testing procedures using beat-by-beat finger plethysmography. The 
plethysmographic cuff was placed around the middle phalanx of the finger, and the 
modulated cuff pressure maintained transmural pressure at an effective zero. Prior to the 
exercise, the finger blood pressure was calibrated using brachial blood pressure. The 
beat-by-beat results were subsequently analyzed using the Beatscope software 
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(Finapres Medical Systems BV, Amsterdam, Netherlands), which also calculated cardiac 
output using the validated Model Flow method and total peripheral resistance. 
 A pulse oximeter (Nellcor N-20P, Colin Corporation, Hayashi Komaki, Japan) was 
used to measure oxygen saturation of arterial hemoglobin noninvasively. This sensor was 
placed on the index finger of each participant during all conditions.  
 Data analysis was performed using the Statistical Package for the Social Sciences 
version 22 (SPSS, IBM Corp., Armonk, NY). Normality of the data was confirmed with a 
Shapiro-Wilk test. A repeated measures analysis of variance was utilized to compare 
changes from baseline of each dependent variable to changes during each of the 
maneuvers. The Greenhouse-Geisser correction of degrees of freedom was used when 
sphericity assumptions were violated. Significant effects were further analyzed with 
Bonferroni post hoc comparisons. A priori power analysis has been conducted using the 
program G*Power (version 3.1.9.2).  With an effect size of 0.3 and power of .90, only 19 
participants would have been required to reach statical significance for each of our 
dependent variables. As such, the overall sample size of 20 participants in this study 








Table 3. Selected Participant Characteristics 
Variable    Means ± SD  
Age, years  26 ± 3  
Males/Females, n  10 / 10  
Height, cm  174 ± 10  
Body weight, kg  71 ± 14  
BMI, kg/m
2  23 ± 3  
Heart rate, bpm  60 ± 12  
Systolic BP, mmHg  117 ± 10  
Mean BP, mmHg  87 ± 6  
Diastolic BP, mmHg  70 ± 7  
htPWV, m/s  6.5 ± 1.8  
CAVI  6.0 ± 0.5  
Ankle Brachial Index   1.06 ± 0.1  
BMI = body mass index; BP = blood pressure;  
htPWV = heart thigh pulse wave velocity;  








Participant Characteristics and Cardiovascular Measures 
 The participant characteristics are presented in Table 3. Experimental data are 
presented in Table 4. A significant increase in heart rate was observed with exercise, 
apnea, and facial immersion when compared with rest (F = [1,19] 16.405, p<0.001; Figure 
3). However, simulated diving (the diving reflex) brought the heart rate down to resting 
levels (p = 0.124). Oxygen saturation did not change with any experimental conditions (p 
= 0.190). Mean blood pressure was significantly elevated during all conditions (F = [1,19] 
34.311, p<0.001; Figure 5), with a further elevation observed during simulated diving 
when compared with exercise (p<0.001), apnea (p=0.016), and facial immersion 
(p<0.001). Stroke volume did not change significantly with any condition (F = [1,19] 2.521, 
p=0.091; Figure 3). Cardiac output increased with all conditions (F = [1,19] 16.844, p<0.001; 
Figure 3), with an attenuated response during simulated diving when compared with 
exercise and facial immersion (p=0.002; p=0.026, respectively). Total peripheral 
resistance was attenuated during exercise and facial immersion when compared with rest 
(F = [1,19] 8.139, p<0.001; Figure 3). Additionally, total peripheral resistance was 
augmented during simulated diving when compared with exercise (p<0.001), apnea 
(p=0.008), and facial immersion (p=0.003).  
Carotid Artery Measurements 
 Carotid pulse pressure increased with all experimental conditions when compared 
with rest (F = [1,19] 17.180, p<0.001; Figure 5).  Arterial compliance increased with 
simulated diving when compared with rest (F = [1,19] 9.109, p=0.007; Figure 4), and was 
augmented when compared with exercise and apnea (p=0.007; p<0.001, respectively). 
53 
 
Cross-sectional compliance increased with all conditions (F = [1,19] 27.525, p<0.001) with 
a greater increase observed during simulated diving compared to exercise (p<0.001), 
apnea (p<0.001), and facial immersion (p=0.003). Facial immersion also augmented 
cross-sectional compliance more than exercise (p<0.001). Distensibility coefficient 
increased during simulated diving when compared with rest (F = [1,19] 4.197, p=0.023), 
and was greater during simulated diving when compared with exercise and apnea (p = 
0.008; p<0.001, respectively). β-stiffness index decreased with each condition (F = [1,19] 
10.127, p < 0.001; Figure 4), with the greatest decrease observed during simulated diving 
when compared to exercise (p<0.001), apnea (p<0.001), and facial immersion (p=0.015). 
Carotid pulse wave velocity decreased during simulated diving when compared with rest 
(F = [1,19] = 4.087, p=0.001), and was lower when compared to exercise and apnea 
(p=0.002; p<0.001, respectively). Lastly, carotid blood flow velocity increased during all 
conditions (F = [1,19] 9.801, p<0.001; Figure 5), with an augmented response during 
simulated diving when compared to exercise and apnea (p=0.008; p=0.001, respectively). 
 Moreover, since there was an even number of male and female participants an 
exploratory analysis was conducted to determine any sex differences in the main outcome 
variables. There was no significant interaction effect for condition by sex for arterial 
compliance (F = [1,19] 2.058, p=0.118), cross-sectional compliance (F = [1,19] 0.315, 
p=0.793), distensibility coefficient (F = [1,19] 2.420, p=0.081), and β-stiffness index (F = 




Table 4. Cardiovascular Responses to Experimental Conditions 
Variable   Rest EX EX+A EX+FI EX+A+FI p-value 
Heart Rate, bpm  76 ± 4 105 ± 5
*† 92 ± 7*† 99 ± 6*† 85 ± 7 <0.001 
Oxygen Saturation, %  97.8 ± 0.3 97.8 ± 0.4 97.5 ± 0.4 97.7 ± 0.3 97.3 ± 0.4 0.190 
Mean Blood Pressure, mmHg  91 ± 4 107 ± 4
*† 122 ± 4*† 115 ± 6*† 132 ± 5* <0.001 
Stroke Volume, mL/beat  81 ± 5 92 ± 6 97 ± 7 94 ± 6 98 ± 11 0.091 
Cardiac Output, L/min  5.8 ± 0.2 9.3 ± 0.5
*† 8.6 ± 0.6* 8.9 ± 0.5*† 7.5 ± 0.6* <0.001 
Total Peripheral Resistance, 
dynes/sec/cm
-5  1343 ± 94 951 ± 72
*† 1253 ± 147† 1140 ± 101*† 1624 ± 186 <0.001 
Carotid Pulse Pressure, mmHg  40 ± 2 61 ± 3
* 68 ± 4*  61 ± 4* 69 ± 4* <0.001 
Arterial Compliance, m/kPa x 10
-4  1.6 ± 0.1 1.5 ± 0.1





5  3.2 ± 0.2 4.5 ± 0.3
*† 4.8 ± 0.3*† 5.6 ± 0.4*† 7.3 ± 0.5* <0.001 
Distensibility Coefficient, 1/kPa x 10
-2  5.3 ± 0.4 5.3 ± 0.5
† 4.8 ± 0.3† 6.2 ± 0.6 6.9 ± 0.5* 0.023 
β-stiffness Index  4.8 ± 0.4 3.9 ± 0.3
*† 3.7 ± 0.2*† 3.3 ± 0.3*† 2.5 ± 0.2* <0.001 
Carotid Pulse Wave Velocity, m/s  4.4 ± 0.2 4.4 ± 0.1
† 4.7 ± 0.2† 4.2 ± 0.2  3.8 ± 0.1* 0.011 
Carotid Blood Flow Velocity, cm/s   92 ± 3 103 ± 4*† 104 ± 4*† 114 ± 5* 117 ± 5* <0.001 
Data are means ± SEM. *p<0.05 vs. Rest, †p<0.05 vs. Simulated Diving (EX+A+FI) 




Figure 3. The heart rate (panel A), total peripheral resistance (TPR; panel B), stroke 
volume (panel C), and cardiac output (panel D) response to each experimental 
condition (EX= Exercise; A= Apnea; FI= Facial Immersion). *p<0.05 vs. Rest. †p<0.05 




































































































































Figure 4. The arterial compliance (AC; panel A), and β-stiffness index (panel B) 
response to each experimental condition (EX= Exercise; A= Apnea; FI= Facial 































































Figure 5. The mean blood pressure (panel A), carotid pulse pressure (panel B), and 
carotid blood flow velocity (panel C) response to each experimental condition (EX= 






























































































The main aim of this study was to investigate how simulated diving would mediate 
arterial function. To the best of our knowledge, this is the first study to demonstrate that 
carotid arterial compliance is augmented during simulated free diving, likely to help buffer 
and cushion increased arterial pressure waves. Specifically, we found increases in arterial 
compliance, cross-sectional compliance, and distensibility coefficient with simulated 
diving when compared with rest. Importantly, these effects were mostly augmented above 
separate conditions of exercise, apnea, and facial immersion. We also demonstrated 
decreased arterial stiffness (the inverse of arterial compliance) via β-stiffness index and 
carotid pulse wave velocity. Additionally, our study reproduces previous findings that 
carotid blood flow velocity increases during the diving reflex (121).  
The simulated diving in the present study displayed similar cardiovascular 
responses previously observed with the diving reflex. Specifically, the bradycardia during 
simulated free diving is similar to the decreases in heart rate demonstrated with the 
original studies performed in pearl divers (78, 141). Previous research has demonstrated 
that mean arterial blood pressure is increased during free diving, which we observed with 
our participants (13, 43). Additionally, total peripheral resistance increased during 
simulated diving when compared with exercise, indicating a sympathetically-mediated 
peripheral vasoconstriction response (13, 64, 171). Cardiac output has been 
demonstrated to not change with the diving reflex (171). Although we observed an 
increase in cardiac output from rest with simulated diving (due to the superimposed 
exercise), there was a decrease in cardiac output when compared with exercise alone. 
As such, cardiac output is decreased via bradycardia to conserve oxygen during 
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simulated diving (13, 95). Previous research demonstrated that stroke volume increases 
during free diving due to a central shift of blood flow with hydrostatic pressure, which 
increases cardiac pre-load (97). However, we did not observe a significant increase in 
stroke volume in our simulated diving, likely due to the lack of full body water immersion 
and the associated hydrostatic pressure that occurs with increased diving depths.  
Exercise 
 To isolate the effects of exercise on the cardiovascular responses from simulated 
diving on our outcome variables, we compared the responses between simulated diving 
and exercise alone. Of course, exercise increases demand on the cardiovascular system 
to meet the blood flow requirements to the working muscles. Autonomic control of 
cardiovascular responses during exercise are primarily mediated by central command, 
the exercise pressor reflex, the arterial baroreflex, cardiopulmonary baroreceptors, and 
arterial chemoreceptors (44). By comparing simulated diving to the exercise stimulus, we 
can infer how the diving reflex contributes to the cardiovascular responses. Importantly, 
acute exercise has been demonstrated to increase arterial compliance (92, 115). We 
effectively demonstrated an augmented response in arterial compliance with simulated 
diving when compared with exercise alone.   
Apnea 
 Apnea produces enough stimulus to trigger a decrease in heart rate, although 
bradycardia is blunted during apnea alone when compared with facial immersion and 
apnea together (143, 158). During breath holding, there is increased anaerobic 
metabolism as increases in plasma lactate concentration are observed (6). During apnea, 
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there is also reduced oxygen uptake from the lungs to the blood, thereby conserving lung 
oxygen reserve (86). Hypercapnia has been demonstrated with apnea (6), which elevates 
blood pressure via chemoreceptor stimulation. We found that apnea did not influence 
arterial compliance or arterial stiffness any more than exercise. However, simulated diving 
enhanced these responses when compared to apnea and exercise.  
Facial Immersion 
Additionally, we wanted to isolate the effect of facial immersion in cold water (10ºC) 
from apnea by providing a snorkeling device to allow breathing. Facial immersion in cold 
water triggers a neuronal afferent response from the trigeminal nerve (3). The nerve fibers 
innervating the anterior nasal mucosa and paranasal region are essential for this reflex 
via chemesthetic trigeminal chemoreceptors (103). These afferent neuronal signals are 
transmitted to the brainstem, resulting in efferent neuronal signals that activate the 
sympathetic and parasympathetic nervous systems (muscarinic M2 receptors and the 
vagus nerve), which induce peripheral vasoconstriction and bradycardia, respectively. 
Indeed, facial immersion in cold water without apnea resulted in bradycardia due to 
increased vagal tone and increased total peripheral resistance when compared with the 
exercise condition. Moreover, facial immersion increased cross-sectional compliance 
more than exercise. Since arterial compliance accounts for the change in blood pressure 
on the distensibility of the artery, we can assume a withdrawal of sympathetic tone on the 
carotid artery is responsible for the increased compliance during facial immersion (166). 
Indeed, arterial compliance has previously been shown to decrease with elevated levels 
of muscle sympathetic nerve activity independent of blood pressure changes (59). 
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Notably, simulated diving enhanced these responses (cross-sectional compliance) when 
compared to facial immersion. 
This study is not without limitations. First, our experimental conditions were not 
randomized. However, we allowed the participants to rest between each condition until 
each cardiovascular measure was brought back down to baseline. Second, a cold pressor 
test could have been conducted to control for the influence of cold stress on the 
cardiovascular responses. Although, facial immersion in cold water could be perceived 
as a cold pressor test, this condition was superimposed with exercise. Lastly, we were 
not able to control for the potential effects of hypercapnia during apnea. We are unsure if 
the 20 seconds of apnea superimposed on exercise resulted in a buildup of arterial carbon 
dioxide in our study, as previous research with 40 seconds of apnea superimposed on 
exercise has demonstrated hypercapnia (6).  
 In conclusion, our present study found that simulated free diving results in 
bradycardia, increased mean arterial blood pressure, increased total peripheral 
resistance, increased arterial compliance, increased carotid blood flow velocity, as well 
as decreased cardiac output and decreased atrial stiffness. These extensive 
cardiovascular adjustments aid in redistributing blood flow centrally while buffering 
pulsatile blood flow. These findings are significant because it contributes to scientific 
knowledge about the influence of interaction of multiple stimuli on the cardiovascular 
system’s blood flow redistribution and regulation during simulated free diving. Ultimately, 
such knowledge helps us further understand how the diving reflex preserves oxygen and 




CHAPTER VI: SUMMARY & FUTURE DIRECTIONS 
 Typically, blood pressure is used in a clinical setting to determine patients’ risk for 
developing cardiovascular disease. However, there are several noninvasive 
measurements of vascular function that provide prognostic utility. These measurements 
include endothelial function, arterial stiffness, and arterial compliance. For example, a 1% 
increase of FMD results in an 8-13% decreased risk of cardiovascular events. While a 1 
m/s increase cfPWV is associated with a 7% increased risk of cardiovascular events. 
Similarly, decreased arterial compliance increases risk of end-organ damage (e.g., heart, 
brain). As such, this dissertation aimed to demonstrate how each of the noninvasive 
measurements of vascular function could be used to conduct an intervention, assess 
clinical feasibility, and a physiological investigation. 
 The first study demonstrated that 24-hour ambulatory blood pressure monitoring 
did not influence endothelial function via ischemic preconditioning. These findings have 
implications in that ambulatory blood pressure monitoring and FMD could be measured 
in tandem with no interference, as this is common practice in many cardiovascular 
research studies. The second study demonstrated that a novel and easy-to-use 
measurement of central arterial stiffness, htPWV, has good agreement with the reference 
standard for arterial stiffness, cfPWV. Although arterial stiffness is an excellent predictor 
for future cardiovascular events, it has not been widely used in clinical settings due to it 
technical nature. This study’s findings support the used of htPWV in clinical settings due 
its potential diagnostic utility. Lastly, the third study demonstrated that simulated free 
diving results in bradycardia, increased blood pressure, increased total peripheral 
resistance, increased carotid blood flow velocity, and decreased cardiac output. More 
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importantly, carotid arterial compliance was significantly elevated and arterial stiffness 
decreased during the simulated diving maneuver. These findings contribute to scientific 
knowledge about the interaction of multiple stimuli on the cardiovascular system’s blood 
flow redistribution and regulation during simulated free diving helping to preserve oxygen 
and perfuse vital organs.  
Future studies should investigate if longer durations of ambulatory blood pressure 
monitoring influence endothelial function. Additionally, determine how effective of a 
predictor htPWV is for cardiovascular events when compared to cfPWV in large 
population-based studies. Finally, verify the results of this study on how arterial function 
is modulated during free diving in the sea utilizing innovative technologies that provide 
data acquisition in such a challenging environment. In conjunction with our current 
findings the additional studies would demonstrate how noninvasive measures of vascular 
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IRB USE ONLY 
Study Number: 2017-07-0043 
Approval Date: 9/12/2017 
Expires: 9/11/2018 
 
Consent for Participation in Research 
 
Title: 24-hour blood pressure measurements and ischemic conditioning 
 
Introduction 
The purpose of this form is to provide you information that may affect your decision as to 
whether or not to participate in this research study.  The person performing the research will 
answer any of your questions.  Read the information below and ask any questions you might 
have before deciding whether or not to take part. If you decide to be involved in this study, 
this form will be used to record your consent. 
 
Purpose of the Study 
You have been asked to participate in a research study about the relationship between 24-
hour blood pressure monitoring and vascular function.  The purpose of this study is to 
determine if wearing a blood pressure monitor for 24-hours a day would change vascular 
function.    
 
A description of this study will be available on http://www.ClinicalTrials.gov as required by 
U.S. Law.  This web site will not include information that can identify you.  At most, the web 
site will include a summary of the results.  You can search this web site at any time. 
 
What will you be asked to do? 
If you agree to participate in this study, you will be asked to wear a blood pressure monitor 
for 24 hours (even when you are sleeping). Before and after wearing the blood pressure 
monitor, we will assess vascular function in the research laboratory.  This study will take a 
total of 26 hours to complete (24 hours of blood pressure monitoring and 1 hour each of 
vascular function testing before and after the blood pressure monitoring) and will include 
approximately 30 study participants.   
 
Health questionnaire will determine if you are eligible to participate and to get a general 
sense of your overall health status.  If you are found to be eligible to participate in the study 
based on the questionnaire, we will perform several measurements described below.     
 
Vascular function will be tested by inflating a cuff that is placed on the arm to block blood 
flow to the hand for 5 minutes.  During these tests, an ultrasound probe will be placed on the 
skin of your arm.  Your body’s response to the stress will be measured (by the ultrasound 
probe placed on the arm) before and after the cuff is released.   
 
24-hour blood pressure monitor will be programmed to record the blood pressure from 6 am 
to 11 pm every 15 minutes and from 11 pm to 6 am every 20 minutes.  You will take this 
blood pressure monitor home and return it the next day.   
 
When you come back to the laboratory to return the blood pressure monitor, we will repeat 
the vascular function test above.          
 
NOTE: 
This is a research study and, therefore, not intended to provide a medical or therapeutic 




equivalent to the standard method of prevention, diagnosis, or treatment of a health condition. 
 
What are the risks involved in this study? 
This research may involve risks that are currently unforeseeable. Possible risks associated 
with this study are temporary discomfort (numbness and/or tingling) at the fingertip during 
and after cuff inflation during the vascular function tests.  These symptoms usually disappear 
within 30 seconds following cuff deflation.      
 
What are the possible benefits of this study? 
You will receive no direct benefit from participating in this study. However, the possible 
benefits of participation are measurements of 24-hour blood pressure and vascular function 
free of charge.  Or you may not gain any benefit at all.      
 
Do you have to participate? 
No, your participation is voluntary. You may decide not to participate at all or, if you start the 
study, you may withdraw at any time.  Withdrawal or refusing to participate will not affect 
your relationship with The University of Texas at Austin (University) in anyway.  
 
If you would like to participate, please sign this informed consent form and return it to the 
investigator.  You will receive a copy of this form. 
  
Will there be any compensation? 
You will not receive any type of payment participating in this study.  
 
What if you are injured because of the study?   
In the event of a research-related injury, it is important that you notify the Principal Investigator 
of the research-related injury immediately. You and/or your insurance company or health care 
plan may be responsible for any charges related to research-related injuries. Compensation for 
an injury resulting from your participation in this research is not available from The University 
of Texas at Austin.  However, you are not waiving any of your legal rights by participating in 
this study.  
 
How will your privacy and confidentiality be protected if you participate in this research 
study? 
Any information that is obtained in this study and that can be identified with you will remain 
confidential and will be released only with your permission.  Your responses will not be 
linked to your name in any written or verbal report of this research project.  The researchers 
might use information learned from this study in scientific journal articles or in presentations.  
None of this information will identify you personally.   
 
If it becomes necessary for the Institutional Review Board to review the study records, 
information that can be linked to you will be protected to the extent permitted by law. Your 
research records will not be released without your consent unless required by law or a court 
order. The data resulting from your participation may be made available to other researchers 
in the future for research purposes not detailed within this consent form. In these cases, the 
data will contain no identifying information that could associate it with you, or with your 
participation in any study. 
 
Whom to contact with questions about the study?   
Prior, during or after your participation you can contact the researcher Hirofumi Tanaka at 512-
232-4801 or send an email to htanaka@austin.utexas.edu for any questions or if you feel that 
you have been harmed.   
 
This study has been reviewed and approved by The University Institutional Review Board and the 
study number is 2017-07-0043. 
 










Whom to contact with questions concerning your rights as a research participant? 
For questions about your rights or any dissatisfaction with any part of this study, you can contact, 




 If you agree to participate, you will bring the signed forms to BEL 842 during your initial 
visit prior to beginning the study. Or you may fill them out at the lab (BEL 842) prior to 
beginning the study.  
 
Signature   
You have been informed about this study’s purpose, procedures, possible benefits and risks, and 
you have received a copy of this form. You have been given the opportunity to ask questions 
before you sign, and you have been told that you can ask other questions at any time. You 
voluntarily agree to participate in this study.  By signing this form, you are not waiving any of 




Printed Name  
 
_________________________________    _________________ 
Signature Date 
 
As a representative of this study, I have explained the purpose, procedures, benefits, and the risks 
involved in this research study. 
 
_________________________________      
Print Name of Person obtaining consent      
 
 
_________________________________    _________________  
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Study Number: 2018-05-0118 
Approval Date: 09/05/2018 
Expires: 07/12/2019 
 
Consent for Participation in Research 
Title: Reproducibility and Validity of Arterial Stiffness Measurements 
Introduction 
The purpose of this form is to provide you information that may affect your decision as to 
whether or not to participate in this research study. The person performing the research will 
answer any of your questions. Read the information below and ask any questions you might 
have before deciding whether or not to take part. If you decide to be involved in this study, 
this form will be used to record your consent. 
 
Purpose of the Study 
You have been asked to participate in a research study to evaluate the reproducibility and 
validity of measurement methodologies of arterial stiffness. To accomplish this aim, 
we will compare values obtained for arterial stiffness from an automatic device to 
those measured using gold standard methodologies (manual methods). This 
measurement is often used by doctors to screen for risks of future cardiovascular 
disease and stroke. 
 
A description of this study will be available on http://www.ClinicalTrials.gov as required by 
U.S. Law. This web site will not include information that can identify you. At most, the web 
site will include a summary of the results. You can search this web site at any time. 
 
What will you be asked to do? 
 
If you agree to participate, you will be asked to participate in one-day testing that 
lasts ~2 hours. During the testing period, measurements described below will be 
made on you. All the measurements will be conducted in the Cardiovascular Aging 
Research Laboratory (room 842) in Bellmont Hall. Before each of the visits you will be 
asked to fast for 4 hours, not have alcohol or caffeine within 12 hours, and abstain from 
strenuous physical activity for 24 hours prior to each visit. 
 
• Health questionnaire will determine if you are eligible to participate and to get a general 
sense of your overall health status. If you are found to be eligible to participate in the 
study based on the questionnaire, we will perform several measurements described 
below. 
 
• Body Measurements of your height and body weight will be assessed on a 
physician’s balance scale. 
 
• Blood pressure will be measured non-invasively in the laboratory via standard 
automated blood pressure cuff that would be found in a Doctor’s office. 
 
• Arterial Stiffness will be measured noninvasively by placing either a painless 
instrument called a Doppler probe or a pencil-like transducer (depending on the 




joint) arteries. This measurement is based on experiments showing that the faster 
your blood pressure travels, the stiffer your arteries are. We will perform this 
measurement using two different methods as follows. 
o First, automatic blood pressure cuffs will be placed on your upper arms 
and ankles. The cuffs will then inflate and slowly deflate to measure your 
arterial stiffness. 
o Next, we will repeat the same procedure manually; we will use hand-held 
probes or transducers on the skin. 
 
All assessments of vascular function will take place in the research laboratory. This study 




This is a research study and, therefore, not intended to provide a medical or therapeutic 
diagnosis or treatment. The intervention provided in the course of this study is not necessarily 
equivalent to the standard method of prevention, diagnosis, or treatment of a health condition. 
 
What are the risks involved in this study? 
Every effort has been made by the investigators to keep the risk and discomfort 
involved in this study to a minimum. Nevertheless, the potential risks associated with 
this study include a slight risk of discomfort associated with the placement of blood 
pressure cuffs at high pressure, and a slight risk of fainting associated with the 
placement of a probe over the carotid (neck) artery. 
 
What are the possible benefits of this study? 
You will receive no direct benefit from participating in this study. However, the possible 
benefits of participation are measurements of blood pressure, heart rate and vascular function. 
Additionally, your participation will contribute to scientific knowledge that is likely to 
result in the establishment of validity for an automatic device to screen for risks 
associated with future cardiovascular disease in men and women. 
 
Do you have to participate? 
No, your participation is voluntary. You may decide not to participate at all or, if you start the 
study, you may withdraw at any time. Withdrawal or refusing to participate will not affect 
your relationship with The University of Texas at Austin (University) in anyway. 
 
If you would like to participate, please sign this informed consent form and return it to the 
investigator. You will receive a copy of this form. 
 
Will there be any compensation? 
No compensation will be provided for participating in this study. 
 
What if you are injured because of the study? 
In the event of a research-related injury, it is important that you notify the Principal Investigator 
of the research-related injury immediately. You and/or your insurance company or health care 
plan may be responsible for any charges related to research-related injuries. Compensation for 
an injury resulting from your participation in this research is not available from The University 





How will your privacy and confidentiality be protected if you participate in this research 
study? 
Any information that is obtained in this study and that can be identified with you will remain 
confidential and will be released only with your permission. Your responses will not be 
linked to your name in any written or verbal report of this research project. The researchers 
might use information learned from this study in scientific journal articles or in presentations. 
None of this information will identify you personally. 
 
If it becomes necessary for the Institutional Review Board to review the study records, 
information that can be linked to you will be protected to the extent permitted by law. Your 
research records will not be released without your consent unless required by law or a court 
order. The data resulting from your participation may be made available to other researchers 
in the future for research purposes not detailed within this consent form. In these cases, the 
data will contain no identifying information that could associate it with you, or with your 
participation in any study. 
 
Whom to contact with questions about the study? 
Prior, during or after your participation you can contact the researcher Hirofumi Tanaka at 512- 
232-4801 or send an email to htanaka@austin.utexas.edu for any questions or if you feel that 
you have been harmed. 
This study has been reviewed and approved by The University Institutional Review Board and the 
study number can be given to you by the research investigator at any time upon request. 
 
Whom to contact with questions concerning your rights as a research participant? 
For questions about your rights or any dissatisfaction with any part of this study, you can contact, 




If you agree to participate, you will bring the signed forms to BEL 842 during your initial 
visit prior to beginning the study. Or you may fill them out at the lab (BEL 842) prior to 
beginning the study. 
Signature 
You have been informed about this study’s purpose, procedures, possible benefits and risks, and 
you have received a copy of this form. You have been given the opportunity to ask questions 
before you sign, and you have been told that you can ask other questions at any time. You 
voluntarily agree to participate in this study. By signing this form, you are not waiving any of 







As a representative of this study, I have explained the purpose, procedures, benefits, and the risks 
involved in this research study. 
 
 





























UT Austin IRB Approved 
Protocol Number: 2019-11-0014 
Approved: 12/16/2019  
 
 
Title of the Project: Interaction of Exercise and Multiple Reflexes 
Principal Investigator: Brandon Fico, M.S., The University of Texas at Austin 
Faculty Advisor: Hirofumi Tanaka, Ph.D., The University of Texas at Austin 
Study Sponsor: No sponsor 
 
Consent to Participate in Research 
Invitation to be Part of a Research Study 
You are invited to be part of a research study. This consent form will help you choose whether 
or not to participate in the study. Feel free to ask if anything is not clear in this consent form. 
 
Important Information about this Research Study 
 
Things you should know: 
• The purpose of the study is to determine the cardiovascular responses during a 
simulated diving maneuver. 
• In order to participate, you must be a healthy adult between the ages of 18 and 45 years 
old. 
• If you choose to participate, you will be asked to exercise at light to moderate intensity 
on a cycle ergometer while holding your breath (apnea) with face immersion in cold 
water and without apnea (10°C/ 50°F). Each breath hold will last up to a maximum of 30 
seconds. During this simulated diving maneuver, a few cardiovascular measurements 
will be recorded. This will take two visits lasting up to 2 hours each. 
• Risks or discomforts from this research include fatigue, syncope (fainting), shortness of 
breath, elevated blood pressure, and skeletal muscle cramping during exercise. 
• There are no direct benefits for participating in the study. However, you will receive 
blood pressure and arterial stiffness assessments.  
• Taking part in this research study is voluntary. You do not have to participate, and you 
can stop at any time. 
More detailed information may be described later in this form. 
Please take time to read this entire form and ask questions before deciding whether to take part 
in this research study. 
What is the study about and why are we doing it? 
You have been asked to participate in a research study investigating the effect of free diving on 
the cardiovascular systems regulation of blood flow and redistribution. The purpose of this study 
is to determine if arterial compliance increases during the diving maneuver. 
 
What will happen if you take part in this study? 
If you agree to take part in this study, you will be asked to come to the laboratory on two 




compliance will be assessed non-invasively.  We will then measure arterial and cardiac function 
during the conditions of apnea, face immersion in cold water with and without apnea, and 
exercise. Additionally, we will combine all the conditions to simulate free diving by conducting 
face immersion in cold water (10°C/50°F) with apnea while exercising on a cycle ergometer with 
simultaneous measurements of your cardiovascular responses. Below are the measurements to 
be taken in detail. 
 
Health questionnaire will determine if you are eligible to participate and to get a general sense 
of your overall health status.  If you are found to be eligible to participate in the study based on 
the questionnaire, we will perform several measurements described below.    
 
Arterial stiffness will be tested by placing blood pressure cuffs on your arms, thighs, and ankles. 
Additionally, electrocardiogram leads will be placed on your arms and a phonocardiogram 
(microphone) will be placed on your chest to listen for the closing of your heart valves. The 
transit time in which it takes the pressure waveforms to travel from proximal to distal cuffs will 
determine the degree of arterial stiffness.  
 
Arterial compliance will be measured by placing an ultrasound transducer and tonometer 
(pressure sensor) on your neck. The ultrasound probe will be placed on one side of your neck 
and the presser sensor will be placed on the other side and will remain in place throughout the 
testing. 
 
Blood pressure and heart rate will be measured by placing a cuff on your middle finger. The cuff 
will be inflated to an effective zero (slight pressure) and will measure changes in your blood 
pressure and heart rate throughout the testing.  
 
Oxygen saturation will be measured by placing a sensor on your index finger. This device uses 
light absorption to measure your oxygen saturation of arterial hemoglobin. 
 
 
How long will you be in this study and how many people will be in the study? 
Participation in this study requires 2 visits, each lasting no more than 2 hours.  
 
What risks and discomforts might you experience from being in this study? 
There are some risks you might experience from being in this study. They include fatigue, 
syncope (fainting), shortness of breath, elevated blood pressure, and skeletal muscle cramping 
during exercise. The potential risks of the proposed studies will be minimized by: (a) using only 
safe, well-established procedures; (b) constant, personal monitoring of each experimental 
session by investigators that have training and experience using the experimental equipment; 
(c) the appropriate clinical supervision and availability of emergency equipment; (d) employing 
complete confidentiality of the record keeping process to be employed.  In the case of 
emergency, standard laboratory procedure to call 911 will be performed. The researchers will let 
you know about any significant new findings (such as additional risks or discomforts) that might 
make you change your mind about participating in this study. 
  
How could you benefit from this study? 
There are no direct benefits for participation in this study. However, from being in this study you 
will receive blood pressure and arterial stiffness assessments. Or you may not gain any benefit 
at all. Although, societal benefits include the advancement of how the cardiovascular system 





What will happen to the samples and/or data we collect from you? 
As part of this study we will collect non-invasive cardiovascular measures during the 
experimental procedures. These measurements will be presented as group average responses 
for research presentations and publications. Any information that is obtained in this study and 
that can be identified with you will remain confidential and will be released only with your 
permission.  Your responses will not be linked to your name in any written or verbal report of 
this research project.  The researchers might use information learned from this study in scientific 
journal articles or in presentations.  None of this information will identify you personally.   
 
How will we protect your information? 
We will protect your information by storing your information in a locked file cabinet in the P.I.’s 
office. Additionally, data will be stored by code, and at no time will any individual data point be 
identified with a particular individual participant. This procedure is applicable to electronic data 
as well. Your name and any other information that can directly identify you will be stored 
separately from the data collected as part of the project. The data or samples that we will collect 
about you will not be shared with any other researchers. We plan to publish the results of this 
study. To protect your privacy, we will not include any information that could directly identify you. 
 
Information about you may be given to the following organizations:  
• Representatives of UT Austin and the UT Austin Institutional Review Board  
 
What will happen to the information we collect about you after the study is over? 
Your name and other information that can directly identify you will be deleted from the research 
data collected as part of the project. The data resulting from your participation may be made 
available to other researchers in the future for research purposes not detailed within this 
consent form. In these cases, the data will contain no identifying information that could 
associate it with you, or with your participation in any study. 
 
What if we learn something about your health that you did not know? 
As part of this study, we may learn medically relevant information about you. If we learn 
something that you and your doctor did not know, we will ask you to follow-up with your 
physician. 
 
How will we compensate you for being part of the study?  
You will not receive any type of payment for your participation. 
 
Who will pay if you are hurt during the study?  
In the event of a research-related injury, it is important that you notify the Principal Investigator 
of the research-related injury immediately. You and/or your insurance company or health care 
plan may be responsible for any charges related to research-related injuries. Compensation for 
an injury resulting from your participation in this research is not available from The University of 
Texas at Austin. You are not waiving any of your legal rights by participating in this study. 
 
What are the costs to you to be part of the study? 
To participate in the research, you will need not need to pay for anything (e.g. a parking pass 





   
 
Your Participation in this Study is Voluntary  
It is totally up to you to decide to be in this research study. Participating in this study is 
voluntary. Your decision to participate will not affect your relationship with The University of 
Texas at Austin. You will not lose any benefits or rights you already had if you decide not to 
participate. Even if you decide to be part of the study now, you may change your mind and stop 
at any time. You do not have to answer any questions you do not want to answer.  
 
If you decide to withdraw before this study is completed, your data will be deleted. 
 
Is it possible that you will be asked to leave the study?  
You may be asked to leave the study if it is determined by the research team that it is unsafe for 
you to continue. If any of the following issues come up, we will have to ask you to stop 
participating: fainting, nausea, or an excessive drop in blood pressure.  
 
Contact Information for the Study Team  









Contact Information for Questions about Your Rights as a Research Participant 
If you have questions about your rights as a research participant, or wish to obtain information, 
ask questions, or discuss any concerns about this study with someone other than the 
researcher(s), please contact the following: 
 
The University of Texas at Austin Institutional Review Board 
Phone: 512-232-1543  
Email: irb@austin.utexas.edu 




By signing this document, you are agreeing to be in this study. We will give you a copy of this 
document for your records. We will keep a copy with the study records.  If you have any 
questions about the study after you sign this document, you can contact the study team using 
the information provided above. 
 
I understand what the study is about and my questions so far have been answered. I agree to 
take part in this study.  
 
______________________________________________________________ 
Printed Subject Name  
 
______________________________________________________________ 

























Cardiovascular Aging Research Laboratory 




Today’s Date ______________ Subject ID __________________________ 
 
 
Please circle the highest grade in school you have completed: 
Elementary school 1 2 3 4 5 6 7 8 
High school  9 10 11 12 
College/Post Grad 13 14 15 16 17 18 19 20+ 
 
What is your marital status?    □Single     □Married;   □ Widowed    □Divorced; Separated 
Ethnic Background:    □Hispanic or Latino      □Not Hispanic or Latino 
Race: 
□White         □American Indian/Alaskan Native  □Pacific Islander 
□Black or African American  □Asian 
       
 
Symptoms or Signs Suggestive of Disease 
Check appropriate box:    
Yes No   
□ □ 1. Have you experienced unusual pain or discomfort in your check, neck, jaw, arms or 
other areas that may be due to heart problems? 
□ □ 2. Have you experienced unusual fatigue or shortness of breath at rest, during usual 
activities, or during mild-to-moderate exercise (e.g., climbing stairs, carrying 
groceries, brisk walking, cycling)? 
□ □ 3. When you stand up, or sometimes during the night while you are sleeping, do you 
have difficulty breathing? 
□ □ 4. Do you lose your balance because of dizziness or do you ever lose consciousness? 
□ □ 5. Do you suffer from swelling of the ankles (ankle edema)? 
□ □ 6. Have you experienced an unusual and rapid throbbing or fluttering of the heart? 
□ □ 7. Have you experienced severe pain in your leg muscles during walking? 
□ □ 8. Has a doctor told you that you have a heart murmur? 
 
 
Chronic Disease Risk Factors 
Check appropriate box: 
 
Yes No   
□ □ 9a. Are you a male over age 45 years or a female over age 55 years? 
□ □  b. Are you a female who has experienced premature menopause? 
□ □  c. If you answered “yes” to 9b, are you on estrogen replacement therapy? 
□ □ 10. Has your father or brother had a heart attack or died suddenly of heart disease 
before the age of 55; has your mother or sister experienced these heart problems 
before the age of 65? 




□ □ 11. Are you a current cigarette smoker? 
□ □ 12. Has a doctor told you that you have high blood pressure (more than 140/90 mm Hg) or 
a heart condition? 
□ □ 13. Is your total serum cholesterol greater than 200 mg/dl, or has a doctor told you that your 
cholesterol is at a high risk-level? 
□ □ 14. Do you have diabetes mellitus? 
□ □ 15. Are you physically inactive and sedentary (little physical activity on the job or during 
leisure time)? 
□ □ 16. Do you have a bone or joint problem that could be made worse by a change in your 
physical activity? 
□ □ 17. During the past year, would you say that you have experienced enough stress, strain, 
and pressure to have a significant effect on your health? 
□ □ 18. Do you eat foods nearly every day that are high in fat and cholesterol such as fatty 
meats, cheese, fried foods, butter, whole milk, or eggs? 
□ □ 19. Do you weigh 30 or more pounds than you should? 
□ □ 20. Do you know of any other reason you should not do physical activity? 
 
Medical History 
21. Please check which of the following conditions you have had or now have.  Also check medical 
conditions in your family (father, mother, brother(s), or sister(s)).  Check as many as apply. 
 
Self Family Medical Condition  Self Family Medical Condition 
□ □ Coronary heart disease, heart 
attack; by-pass surgery 
 □ □ Major injury/fracture to foot, leg, 
knee 
□ □ Arrhythmias  □ □ Major injury to back or neck 
□ □ Angina  □ □ Major injury/fracture to hip or 
shoulder 
□ □ High blood pressure  □ □ Rheumatoid Arthritis 
□ □ Peripheral vascular disease  □ □ Osteoarthritis 
□ □ Phlebitis or emboli  □ □ Gout 
□ □ Other heart problems  □ □ Osteoporosis 
□ □ Stroke  □ □ Fibromyalgia 
□ □ Asthma  □ □ Diabetes mellitus 
□ □ Bronchitis  □ □ Kidney disease 
□ □ COPD (emphysema)  □ □ Cataracts 
□ □ Lung cancer  □ □ Glaucoma 
□ □ Breast cancer  □ □ Hearing loss 
□ □ Prostate cancer  □ □ Depression 
□ □ Skin cancer  □ □ Anxiety, phobias 
□ □ Colorectal cancer  □ □ Eating disorders  
□ □ Other cancer.  Specify:  □ □ Sleeping problems 
□ □ Gallstones/gallbladder 
disease 
 □ □ Substance abuse problems 
(alcohol, other drugs, etc.) 
□ □ Liver disease (cirrhosis)  □ □ Chronic Fatigue Syndrome 






Self Family Medical Condition  Self Family Medical Condition 
□ □ Anemia (low iron)  □ □ Hysterectomy 
□ □ Stomach/duodenal ulcer  □ □ Problems with menstruation 
□ □ Rectal growth or bleeding  □ □ Post-menopausal (date:             ) 
□ □ Crohne’s disease  □ □ Raynaud’s disease 
□ □ Irritable bowel syndrome  □ □ Allergies 
□ □ Marfan’s syndrome     
Any other health problems.  Please specify and include information on any recent illnesses, 
hospitalizations, or surgical procedures. 
 
 
22. Please check any of the following medications you take regularly and give the name of the 
medication. 
Medication    Name of Medication 
□ Heart medicine   ______________________________________ 
□ Blood pressure medicine  ______________________________________ 
□ Blood cholesterol medicine  ______________________________________ 
□ Hormones    ______________________________________ 
□ Birth control medicine  ______________________________________ 
□ Medicine for breathing/lungs ______________________________________ 
□ Insulin    ______________________________________ 
□ Other medicine for diabetes ______________________________________ 
□ Arthritis medicine   ______________________________________ 
□ Medicine for depression  ______________________________________ 
□ Medicine for anxiety  ______________________________________ 
□ Thyroid medicine   ______________________________________ 
□ Medicine for ulcers   ______________________________________ 
□ Painkiller medicine   ______________________________________ 
□ Allergy medicine   ______________________________________ 
□ Other (please specify)  ______________________________________ 
□ Do you have any drug allergies? ______________________________________ 
□ Dietary supplements (please specify)  ____________________________________ 
 
Body Weight 
23. What is the most you have ever weighed? ______________ pounds 
24. Are you now trying to: 
□ Lose weight  □ Gain weight  □ Stay about the same       □ Not trying to do anything 
 
Stress 
25. During the past month, how would you rate your overall level of stress? 
□ Very high  □ High  □ Moderate  □ Low 
26. In the past year, how much effect has stress had on your health? 
□ A lot   □ Some  □ Hardly any or none 
27. On average, how many hours of sleep do you get in a 24-hour period? 





28. How would you describe your cigarette smoking habits? 
□ Never smoked 
□ Used to smoke.  How many years has it been since you smoked?  _______ years 
□ Still smoke.  How many cigarettes a day do you smoke on average? ___cigarettes/day 
 
29. How many alcoholic drinks do you consume? (A “drink” is a glass of wine, a wine cooler, a 16oz 
bottle/12oz can of beer, a shot glass of liquor, or a mixed drink). 
□ Never use alcohol  □ Less than 1 per week □ 1-6 per week □ 1 per day 
□ 2-3 per day   □ More than 3 per day 
 
30. In one sitting, how many drinks do you typically consume?  ____________________ 
31. How many cups (8 ounces) of coffee do you drink per day? ____________________ 
32.  How many ounces of sodas containing caffeine do you drink per day? ___________ 
 
Physical Fitness, Physical Activity/Exercise 
33. Considering a 7-Day period (a week), how many times on the average do you do the following 
kinds of exercise for more than 15 minutes during your free time (write on each line the 
appropriate number). 
 
a)  STRENUOUS EXERCISE (HEART BEATS RAPIDLY)  Times Per Week 
     (i.e. running, jogging, hockey, football, soccer, squash, basketball, 
     cross country skiing, judo, roller skating, vigorous swimming,   ______________ 
     vigorous long distance bicycling) 
 
b) MODERATE EXERCISE (NOT EXHAUSTING)   
 (i.e. fast walking, baseball, tennis, easy bicycling, volleyball, 
 badminton, easy swimming, alpine skiing, popular and folk dancing)  _____________ 
 
c) MILD EXERCISE (MINIMAL EFFORT) 
 (i.e. yoga, archery, fishing from river bank, bowling, horseshoes, golf, 
 snow-mobiling, easy walking)       _____________ 
  
34. Considering a 7-Day period (a week), during your leisure-time, how often do you engage in any 
regular activity long enough to work up a sweat (heart beats rapidly) 
 
   □ OFTEN  □ SOMETIMES □ NEVER/RARELY 
 
35. How long have you exercised or played sports regularly? 
 □ I do not exercise regularly □ Less than 1 year □ 1-2 years 
□ 2-5 years            □ 5-10 years                        □ More than 10 years 
 
Occupational Health 
36. Please describe your main job title and duties. 
 
________________________________________________________________________ 
37. How much hard physical work is required on your job? 
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